KR20190103295A - Cured film formation composition, orientation material, and phase difference material - Google Patents
Cured film formation composition, orientation material, and phase difference material Download PDFInfo
- Publication number
- KR20190103295A KR20190103295A KR1020197022789A KR20197022789A KR20190103295A KR 20190103295 A KR20190103295 A KR 20190103295A KR 1020197022789 A KR1020197022789 A KR 1020197022789A KR 20197022789 A KR20197022789 A KR 20197022789A KR 20190103295 A KR20190103295 A KR 20190103295A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- carbon atoms
- fluorine
- cured film
- alkyl group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 63
- 239000000463 material Substances 0.000 title claims abstract description 47
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 89
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 75
- 229920000642 polymer Polymers 0.000 claims abstract description 39
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 35
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 25
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 22
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 17
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims abstract description 16
- 239000007870 radical polymerization initiator Substances 0.000 claims abstract description 11
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 6
- -1 acryl group Chemical group 0.000 claims description 134
- 229910052731 fluorine Inorganic materials 0.000 claims description 64
- 125000003545 alkoxy group Chemical group 0.000 claims description 53
- 239000011737 fluorine Substances 0.000 claims description 53
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 50
- 239000000178 monomer Substances 0.000 claims description 31
- 125000000962 organic group Chemical group 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
- 125000002345 steroid group Chemical group 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 125000001153 fluoro group Chemical group F* 0.000 claims description 11
- 125000000623 heterocyclic group Chemical group 0.000 claims description 10
- 125000005647 linker group Chemical group 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- 150000002221 fluorine Chemical class 0.000 claims description 3
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims description 3
- 125000005641 methacryl group Chemical group 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 239000004973 liquid crystal related substance Substances 0.000 abstract description 28
- 229920005989 resin Polymers 0.000 abstract description 11
- 239000011347 resin Substances 0.000 abstract description 11
- 230000035945 sensitivity Effects 0.000 abstract description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 59
- 229910052802 copper Inorganic materials 0.000 description 59
- 239000010949 copper Substances 0.000 description 59
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 58
- 229920006243 acrylic copolymer Polymers 0.000 description 51
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 42
- 239000000243 solution Substances 0.000 description 33
- 150000001875 compounds Chemical class 0.000 description 26
- 239000000758 substrate Substances 0.000 description 24
- 239000002904 solvent Substances 0.000 description 21
- 238000006116 polymerization reaction Methods 0.000 description 20
- 125000000524 functional group Chemical group 0.000 description 19
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 150000002148 esters Chemical class 0.000 description 16
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 14
- 229920002284 Cellulose triacetate Polymers 0.000 description 12
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 12
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 8
- 239000007809 chemical reaction catalyst Substances 0.000 description 8
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 7
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 239000002685 polymerization catalyst Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QPRQEDXDYOZYLA-UHFFFAOYSA-N 2-methylbutan-1-ol Chemical compound CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 125000003700 epoxy group Chemical group 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 6
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 6
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 5
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- NGZUCVGMNQGGNA-UHFFFAOYSA-N 7-[5-(2-acetamidoethyl)-2-hydroxyphenyl]-3,5,6,8-tetrahydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid 7-[5-(2-amino-2-carboxyethyl)-2-hydroxyphenyl]-3,5,6,8-tetrahydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid 3,5,6,8-tetrahydroxy-7-[2-hydroxy-5-(2-hydroxyethyl)phenyl]-9,10-dioxoanthracene-1,2-dicarboxylic acid 3,6,8-trihydroxy-1-methyl-9,10-dioxoanthracene-2-carboxylic acid Chemical compound Cc1c(C(O)=O)c(O)cc2C(=O)c3cc(O)cc(O)c3C(=O)c12.OCCc1ccc(O)c(c1)-c1c(O)c(O)c2C(=O)c3cc(O)c(C(O)=O)c(C(O)=O)c3C(=O)c2c1O.CC(=O)NCCc1ccc(O)c(c1)-c1c(O)c(O)c2C(=O)c3cc(O)c(C(O)=O)c(C(O)=O)c3C(=O)c2c1O.NC(Cc1ccc(O)c(c1)-c1c(O)c(O)c2C(=O)c3cc(O)c(C(O)=O)c(C(O)=O)c3C(=O)c2c1O)C(O)=O NGZUCVGMNQGGNA-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 125000002755 pyrazolinyl group Chemical group 0.000 description 4
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 102100026735 Coagulation factor VIII Human genes 0.000 description 3
- 239000005264 High molar mass liquid crystal Substances 0.000 description 3
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000012965 benzophenone Substances 0.000 description 3
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 3
- 239000003822 epoxy resin Substances 0.000 description 3
- 238000010304 firing Methods 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 229920000647 polyepoxide Polymers 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 150000003673 urethanes Chemical class 0.000 description 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 2
- GGLZAFUNYQEDJN-UHFFFAOYSA-N 1-(2-methyl-4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound CC1=CC(SC)=CC=C1C(=O)C(C)N1CCOCC1 GGLZAFUNYQEDJN-UHFFFAOYSA-N 0.000 description 2
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 2
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 description 2
- WMYINDVYGQKYMI-UHFFFAOYSA-N 2-[2,2-bis(hydroxymethyl)butoxymethyl]-2-ethylpropane-1,3-diol Chemical compound CCC(CO)(CO)COCC(CC)(CO)CO WMYINDVYGQKYMI-UHFFFAOYSA-N 0.000 description 2
- MUUOUUYKIVSIAR-UHFFFAOYSA-N 2-but-3-enyloxirane Chemical compound C=CCCC1CO1 MUUOUUYKIVSIAR-UHFFFAOYSA-N 0.000 description 2
- UKTHULMXFLCNAV-UHFFFAOYSA-N 2-hex-5-enyloxirane Chemical compound C=CCCCCC1CO1 UKTHULMXFLCNAV-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- VVBLNCFGVYUYGU-UHFFFAOYSA-N 4,4'-Bis(dimethylamino)benzophenone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=CC=C(N(C)C)C=C1 VVBLNCFGVYUYGU-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- NTPLXRHDUXRPNE-UHFFFAOYSA-N 4-methoxyacetophenone Chemical compound COC1=CC=C(C(C)=O)C=C1 NTPLXRHDUXRPNE-UHFFFAOYSA-N 0.000 description 2
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 2
- FYYIUODUDSPAJQ-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]heptan-4-ylmethyl 2-methylprop-2-enoate Chemical compound C1C(COC(=O)C(=C)C)CCC2OC21 FYYIUODUDSPAJQ-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000006087 Silane Coupling Agent Substances 0.000 description 2
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 2
- MPIAGWXWVAHQBB-UHFFFAOYSA-N [3-prop-2-enoyloxy-2-[[3-prop-2-enoyloxy-2,2-bis(prop-2-enoyloxymethyl)propoxy]methyl]-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C MPIAGWXWVAHQBB-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- VYHBFRJRBHMIQZ-UHFFFAOYSA-N bis[4-(diethylamino)phenyl]methanone Chemical class C1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1 VYHBFRJRBHMIQZ-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- PODOEQVNFJSWIK-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethoxyphenyl)methanone Chemical compound COC1=CC(OC)=CC(OC)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 PODOEQVNFJSWIK-UHFFFAOYSA-N 0.000 description 2
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- WPHGSKGZRAQSGP-UHFFFAOYSA-N norcarane Chemical compound C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical compound ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 2
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- DWWMSEANWMWMCB-UHFFFAOYSA-N tribromomethylsulfonylbenzene Chemical compound BrC(Br)(Br)S(=O)(=O)C1=CC=CC=C1 DWWMSEANWMWMCB-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- FDYDISGSYGFRJM-UHFFFAOYSA-N (2-methyl-2-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC1C(OC(=O)C(=C)C)(C)C2C3 FDYDISGSYGFRJM-UHFFFAOYSA-N 0.000 description 1
- YRPLSAWATHBYFB-UHFFFAOYSA-N (2-methyl-2-adamantyl) prop-2-enoate Chemical compound C1C(C2)CC3CC1C(C)(OC(=O)C=C)C2C3 YRPLSAWATHBYFB-UHFFFAOYSA-N 0.000 description 1
- LAXOSKGHJOPZMF-UHFFFAOYSA-N (2-propyl-2-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC1C(CCC)(OC(=O)C(C)=C)C2C3 LAXOSKGHJOPZMF-UHFFFAOYSA-N 0.000 description 1
- AURQHUVLTRSLGM-UHFFFAOYSA-N (2-propyl-2-adamantyl) prop-2-enoate Chemical compound C1C(C2)CC3CC1C(CCC)(OC(=O)C=C)C2C3 AURQHUVLTRSLGM-UHFFFAOYSA-N 0.000 description 1
- PSGCQDPCAWOCSH-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) prop-2-enoate Chemical compound C1CC2(C)C(OC(=O)C=C)CC1C2(C)C PSGCQDPCAWOCSH-UHFFFAOYSA-N 0.000 description 1
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- MSAHTMIQULFMRG-UHFFFAOYSA-N 1,2-diphenyl-2-propan-2-yloxyethanone Chemical compound C=1C=CC=CC=1C(OC(C)C)C(=O)C1=CC=CC=C1 MSAHTMIQULFMRG-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QUQJISPCBFLEDB-UHFFFAOYSA-N 1,6-diisocyanatohexane;ethyl carbamate Chemical class CCOC(N)=O.O=C=NCCCCCCN=C=O QUQJISPCBFLEDB-UHFFFAOYSA-N 0.000 description 1
- CNDOSNMFHUSKGN-UHFFFAOYSA-N 1-(2-hydroxyphenyl)pyrrole-2,5-dione Chemical compound OC1=CC=CC=C1N1C(=O)C=CC1=O CNDOSNMFHUSKGN-UHFFFAOYSA-N 0.000 description 1
- ZVEMLYIXBCTVOF-UHFFFAOYSA-N 1-(2-isocyanatopropan-2-yl)-3-prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC=CC(C(C)(C)N=C=O)=C1 ZVEMLYIXBCTVOF-UHFFFAOYSA-N 0.000 description 1
- HUDYANRNMZDQGA-UHFFFAOYSA-N 1-[4-(dimethylamino)phenyl]ethanone Chemical compound CN(C)C1=CC=C(C(C)=O)C=C1 HUDYANRNMZDQGA-UHFFFAOYSA-N 0.000 description 1
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 1
- IGGDKDTUCAWDAN-UHFFFAOYSA-N 1-vinylnaphthalene Chemical compound C1=CC=C2C(C=C)=CC=CC2=C1 IGGDKDTUCAWDAN-UHFFFAOYSA-N 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- VBHXIMACZBQHPX-UHFFFAOYSA-N 2,2,2-trifluoroethyl prop-2-enoate Chemical compound FC(F)(F)COC(=O)C=C VBHXIMACZBQHPX-UHFFFAOYSA-N 0.000 description 1
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- DXUMYHZTYVPBEZ-UHFFFAOYSA-N 2,4,6-tris(trichloromethyl)-1,3,5-triazine Chemical compound ClC(Cl)(Cl)C1=NC(C(Cl)(Cl)Cl)=NC(C(Cl)(Cl)Cl)=N1 DXUMYHZTYVPBEZ-UHFFFAOYSA-N 0.000 description 1
- BTJPUDCSZVCXFQ-UHFFFAOYSA-N 2,4-diethylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC(CC)=C3SC2=C1 BTJPUDCSZVCXFQ-UHFFFAOYSA-N 0.000 description 1
- AENZGWONVTXLRC-UHFFFAOYSA-N 2-(2,5-dioxopyrrol-1-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N1C(=O)C=CC1=O AENZGWONVTXLRC-UHFFFAOYSA-N 0.000 description 1
- OLQFXOWPTQTLDP-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCO OLQFXOWPTQTLDP-UHFFFAOYSA-N 0.000 description 1
- RWXMAAYKJDQVTF-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl prop-2-enoate Chemical compound OCCOCCOC(=O)C=C RWXMAAYKJDQVTF-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- GHGCHYOFZGPCNY-UHFFFAOYSA-N 2-(2-methylprop-2-enoylamino)benzoic acid Chemical compound CC(=C)C(=O)NC1=CC=CC=C1C(O)=O GHGCHYOFZGPCNY-UHFFFAOYSA-N 0.000 description 1
- IHYBDNMNEPKOEB-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 6-hydroxyhexanoate Chemical compound CC(=C)C(=O)OCCOC(=O)CCCCCO IHYBDNMNEPKOEB-UHFFFAOYSA-N 0.000 description 1
- RKYJPYDJNQXILT-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxycarbonyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)OCCOC(=O)C=C RKYJPYDJNQXILT-UHFFFAOYSA-N 0.000 description 1
- KJOLAZDWVDOTSF-UHFFFAOYSA-N 2-(prop-2-enoylamino)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1NC(=O)C=C KJOLAZDWVDOTSF-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- YIJYFLXQHDOQGW-UHFFFAOYSA-N 2-[2,4,6-trioxo-3,5-bis(2-prop-2-enoyloxyethyl)-1,3,5-triazinan-1-yl]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCN1C(=O)N(CCOC(=O)C=C)C(=O)N(CCOC(=O)C=C)C1=O YIJYFLXQHDOQGW-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- JQCWCBBBJXQKDE-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.COC(O)COCCOCCO JQCWCBBBJXQKDE-UHFFFAOYSA-N 0.000 description 1
- COORVRSSRBIIFJ-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(O)COCCOCCO COORVRSSRBIIFJ-UHFFFAOYSA-N 0.000 description 1
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 1
- FIQBJLHOPOSODG-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxycarbonyl]benzoic acid Chemical compound CC(=C)C(=O)OCCOC(=O)C1=CC=CC=C1C(O)=O FIQBJLHOPOSODG-UHFFFAOYSA-N 0.000 description 1
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 1
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 1
- NREFJJBCYMZUEK-UHFFFAOYSA-N 2-[2-[4-[2-[4-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]phenyl]propan-2-yl]phenoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound C1=CC(OCCOCCOC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCCOCCOC(=O)C(C)=C)C=C1 NREFJJBCYMZUEK-UHFFFAOYSA-N 0.000 description 1
- PTJWCLYPVFJWMP-UHFFFAOYSA-N 2-[[3-hydroxy-2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)COCC(CO)(CO)CO PTJWCLYPVFJWMP-UHFFFAOYSA-N 0.000 description 1
- UGIJCMNGQCUTPI-UHFFFAOYSA-N 2-aminoethyl prop-2-enoate Chemical compound NCCOC(=O)C=C UGIJCMNGQCUTPI-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- KMNCBSZOIQAUFX-UHFFFAOYSA-N 2-ethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OCC)C(=O)C1=CC=CC=C1 KMNCBSZOIQAUFX-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- FWWXYLGCHHIKNY-UHFFFAOYSA-N 2-ethoxyethyl prop-2-enoate Chemical compound CCOCCOC(=O)C=C FWWXYLGCHHIKNY-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- GWZMWHWAWHPNHN-UHFFFAOYSA-N 2-hydroxypropyl prop-2-enoate Chemical compound CC(O)COC(=O)C=C GWZMWHWAWHPNHN-UHFFFAOYSA-N 0.000 description 1
- DPNXHTDWGGVXID-UHFFFAOYSA-N 2-isocyanatoethyl prop-2-enoate Chemical compound C=CC(=O)OCCN=C=O DPNXHTDWGGVXID-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- YXYJVFYWCLAXHO-UHFFFAOYSA-N 2-methoxyethyl 2-methylprop-2-enoate Chemical compound COCCOC(=O)C(C)=C YXYJVFYWCLAXHO-UHFFFAOYSA-N 0.000 description 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 1
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 1
- IFDUTQGPGFEDHJ-UHFFFAOYSA-N 2-methylprop-2-enoic acid;oxolan-2-one Chemical compound CC(=C)C(O)=O.O=C1CCCO1 IFDUTQGPGFEDHJ-UHFFFAOYSA-N 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 1
- BNCADMBVWNPPIZ-UHFFFAOYSA-N 2-n,2-n,4-n,4-n,6-n,6-n-hexakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine Chemical compound COCN(COC)C1=NC(N(COC)COC)=NC(N(COC)COC)=N1 BNCADMBVWNPPIZ-UHFFFAOYSA-N 0.000 description 1
- XLLXMBCBJGATSP-UHFFFAOYSA-N 2-phenylethenol Chemical compound OC=CC1=CC=CC=C1 XLLXMBCBJGATSP-UHFFFAOYSA-N 0.000 description 1
- SLJFKNONPLNAPF-UHFFFAOYSA-N 3-Vinyl-7-oxabicyclo[4.1.0]heptane Chemical compound C1C(C=C)CCC2OC21 SLJFKNONPLNAPF-UHFFFAOYSA-N 0.000 description 1
- NWKKCUWIMOZYOO-UHFFFAOYSA-N 3-methoxybutyl 2-methylprop-2-enoate Chemical compound COC(C)CCOC(=O)C(C)=C NWKKCUWIMOZYOO-UHFFFAOYSA-N 0.000 description 1
- NPYMXLXNEYZTMQ-UHFFFAOYSA-N 3-methoxybutyl prop-2-enoate Chemical compound COC(C)CCOC(=O)C=C NPYMXLXNEYZTMQ-UHFFFAOYSA-N 0.000 description 1
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 description 1
- YXKKMVGGPRVHIL-UHFFFAOYSA-N 4-(4-pentylcyclohexyl)benzoic acid Chemical compound C1CC(CCCCC)CCC1C1=CC=C(C(O)=O)C=C1 YXKKMVGGPRVHIL-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- YKXAYLPDMSGWEV-UHFFFAOYSA-N 4-hydroxybutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCO YKXAYLPDMSGWEV-UHFFFAOYSA-N 0.000 description 1
- OECTYKWYRCHAKR-UHFFFAOYSA-N 4-vinylcyclohexene dioxide Chemical compound C1OC1C1CC2OC2CC1 OECTYKWYRCHAKR-UHFFFAOYSA-N 0.000 description 1
- VSYIJNDEXXBJFH-UHFFFAOYSA-N 5-isocyanato-2-methylpent-1-en-3-one Chemical compound CC(=C)C(=O)CCN=C=O VSYIJNDEXXBJFH-UHFFFAOYSA-N 0.000 description 1
- FOMNBFSRHKJALH-UHFFFAOYSA-N 5-isocyanatopent-1-en-3-one Chemical compound C=CC(=O)CCN=C=O FOMNBFSRHKJALH-UHFFFAOYSA-N 0.000 description 1
- NUXLDNTZFXDNBA-UHFFFAOYSA-N 6-bromo-2-methyl-4h-1,4-benzoxazin-3-one Chemical compound C1=C(Br)C=C2NC(=O)C(C)OC2=C1 NUXLDNTZFXDNBA-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 101001074560 Arabidopsis thaliana Aquaporin PIP1-2 Proteins 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- UVQATVZCNVYMKL-UHFFFAOYSA-N C(C(=C)C)(=O)OCC(COC(C=C)=O)O.C(C=C)(=O)O Chemical compound C(C(=C)C)(=O)OCC(COC(C=C)=O)O.C(C=C)(=O)O UVQATVZCNVYMKL-UHFFFAOYSA-N 0.000 description 1
- ZPZAQTLGHCDTOH-UHFFFAOYSA-N C(C)(=O)C1=CC=CC=C1.C(C1=CC=CC=C1)C(CC1=CC=C(C=C1)N1CCOCC1)(CC)N(C)C Chemical class C(C)(=O)C1=CC=CC=C1.C(C1=CC=CC=C1)C(CC1=CC=C(C=C1)N1CCOCC1)(CC)N(C)C ZPZAQTLGHCDTOH-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920004552 POLYLITE® Polymers 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-N PYRUVIC-ACID Natural products CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- LCXXNKZQVOXMEH-UHFFFAOYSA-N Tetrahydrofurfuryl methacrylate Chemical compound CC(=C)C(=O)OCC1CCCO1 LCXXNKZQVOXMEH-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- 238000003848 UV Light-Curing Methods 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- YMOONIIMQBGTDU-VOTSOKGWSA-N [(e)-2-bromoethenyl]benzene Chemical compound Br\C=C\C1=CC=CC=C1 YMOONIIMQBGTDU-VOTSOKGWSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical group C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- ULQMPOIOSDXIGC-UHFFFAOYSA-N [2,2-dimethyl-3-(2-methylprop-2-enoyloxy)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C)(C)COC(=O)C(C)=C ULQMPOIOSDXIGC-UHFFFAOYSA-N 0.000 description 1
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 1
- YPCHGLDQZXOZFW-UHFFFAOYSA-N [2-[[4-methyl-3-[[3-prop-2-enoyloxy-2,2-bis(prop-2-enoyloxymethyl)propoxy]carbonylamino]phenyl]carbamoyloxymethyl]-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound CC1=CC=C(NC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C)C=C1NC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C YPCHGLDQZXOZFW-UHFFFAOYSA-N 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FTWHFXMUJQRNBK-UHFFFAOYSA-N alpha-Methylen-gamma-aminobuttersaeure Natural products NCCC(=C)C(O)=O FTWHFXMUJQRNBK-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- FVFZFANLRPXUIE-UHFFFAOYSA-N anthracen-1-yl 2-methylprop-2-enoate Chemical compound C1=CC=C2C=C3C(OC(=O)C(=C)C)=CC=CC3=CC2=C1 FVFZFANLRPXUIE-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- CHIHQLCVLOXUJW-UHFFFAOYSA-N benzoic anhydride Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C1=CC=CC=C1 CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 1
- 239000004841 bisphenol A epoxy resin Substances 0.000 description 1
- 229940106691 bisphenol a Drugs 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- XUGISPSHIFXEHZ-VEVYEIKRSA-N cholesteryl acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XUGISPSHIFXEHZ-VEVYEIKRSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- AZDCYKCDXXPQIK-UHFFFAOYSA-N ethenoxymethylbenzene Chemical compound C=COCC1=CC=CC=C1 AZDCYKCDXXPQIK-UHFFFAOYSA-N 0.000 description 1
- MMVJBWFKSYKXIA-UHFFFAOYSA-N ethoxyethane;2-methylprop-2-enoic acid Chemical compound CCOCC.CC(=C)C(O)=O MMVJBWFKSYKXIA-UHFFFAOYSA-N 0.000 description 1
- LVMRFLWAXIZLNG-UHFFFAOYSA-N ethoxyethane;prop-2-enoic acid Chemical compound CCOCC.OC(=O)C=C LVMRFLWAXIZLNG-UHFFFAOYSA-N 0.000 description 1
- CKSRFHWWBKRUKA-UHFFFAOYSA-N ethyl 2-ethoxyacetate Chemical compound CCOCC(=O)OCC CKSRFHWWBKRUKA-UHFFFAOYSA-N 0.000 description 1
- GFUIDHWFLMPAGY-UHFFFAOYSA-N ethyl 2-hydroxy-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)O GFUIDHWFLMPAGY-UHFFFAOYSA-N 0.000 description 1
- ZANNOFHADGWOLI-UHFFFAOYSA-N ethyl 2-hydroxyacetate Chemical compound CCOC(=O)CO ZANNOFHADGWOLI-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 1
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- PZDUWXKXFAIFOR-UHFFFAOYSA-N hexadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C=C PZDUWXKXFAIFOR-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical compound [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 1
- YSGBMDFJWFIEDF-UHFFFAOYSA-N methyl 2-hydroxy-3-methylbutanoate Chemical compound COC(=O)C(O)C(C)C YSGBMDFJWFIEDF-UHFFFAOYSA-N 0.000 description 1
- HSDFKDZBJMDHFF-UHFFFAOYSA-N methyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OC HSDFKDZBJMDHFF-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- JESXATFQYMPTNL-UHFFFAOYSA-N mono-hydroxyphenyl-ethylene Natural products OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 1
- ICWPRFNZEBFLPT-UHFFFAOYSA-N n-(2-hydroxyphenyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1O ICWPRFNZEBFLPT-UHFFFAOYSA-N 0.000 description 1
- KIQBVKPQYARZTK-UHFFFAOYSA-N n-(2-hydroxyphenyl)prop-2-enamide Chemical compound OC1=CC=CC=C1NC(=O)C=C KIQBVKPQYARZTK-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- SEEYREPSKCQBBF-UHFFFAOYSA-N n-methylmaleimide Chemical compound CN1C(=O)C=CC1=O SEEYREPSKCQBBF-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 description 1
- HVYCQBKSRWZZGX-UHFFFAOYSA-N naphthalen-1-yl 2-methylprop-2-enoate Chemical compound C1=CC=C2C(OC(=O)C(=C)C)=CC=CC2=C1 HVYCQBKSRWZZGX-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- QIWKUEJZZCOPFV-UHFFFAOYSA-N phenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1 QIWKUEJZZCOPFV-UHFFFAOYSA-N 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- MUTNCGKQJGXKEM-UHFFFAOYSA-N tamibarotene Chemical compound C=1C=C2C(C)(C)CCC(C)(C)C2=CC=1NC(=O)C1=CC=C(C(O)=O)C=C1 MUTNCGKQJGXKEM-UHFFFAOYSA-N 0.000 description 1
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
- C08F220/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/08—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated side groups
- C08F290/12—Polymers provided for in subclasses C08C or C08F
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
- C09D133/04—Homopolymers or copolymers of esters
- C09D133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/30—Polarising elements
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nonlinear Science (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Liquid Crystal (AREA)
- Polarising Elements (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
[과제] 우수한 수직배향성과 밀착성을 구비하고, 수지필름 상에서도 고감도로 중합성 액정을 수직으로 배향시킬 수 있는 배향재와, 이러한 배향재를 이용하는 위상차재를 제공하기 위한 경화막 형성 조성물을 제공한다.
[해결수단] (A)수직배향성기와 C=C이중결합을 포함하는 중합성기를 갖는 폴리머, 그리고 (B)라디칼중합개시제를 함유하는 경화막 형성 조성물로서, 상기 수직배향성기는 하기 식(1)로 표시되는 기인 것을 특징으로 하는, 경화막 형성 조성물.
(식 [1] 중, Y1 및 Y2는 단결합 등을 나타내고, Y3은 단결합 또는 탄소원자수 1~15의 알킬렌기를 나타내고, Y4는 단결합 또는 2가의 환상기 등을 나타내고, Y5는 벤젠환, 시클로헥산환 또는 복소환으로부터 선택되는 2가의 환상기를 나타내고, n은 0~4의 정수를 나타내고, n이 2 이상인 경우, Y5끼리는 동일할 수도 상이할 수도 있고, Y6은 수소원자 또는 탄소원자수 1~18의 알킬기 등을 나타낸다.)[PROBLEMS] To provide a cured film-forming composition for providing an alignment material having excellent vertical alignment and adhesion, capable of vertically aligning a polymerizable liquid crystal on a resin film with high sensitivity, and a phase difference material using such an alignment material.
[0011] A cured film-forming composition containing (A) a polymer having a vertically oriented group and a polymerizable group containing a C = C double bond, and (B) a radical polymerization initiator, wherein the vertically oriented group is represented by the following formula (1) It is group displayed, The cured film formation composition characterized by the above-mentioned.
(In formula [1], Y <1> and Y <2> represent a single bond etc., Y <3> represents a single bond or an alkylene group of 1-15 carbon atoms, Y <4> represents a single bond or a bivalent cyclic group, etc., Y 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring, or a hetero ring, n represents an integer of 0 to 4, and when n is 2 or more, Y 5 may be the same or different, and Y 6 Represents a hydrogen atom or an alkyl group having 1 to 18 carbon atoms.)
Description
본 발명은 액정분자를 수직으로 배향시키는 수직배향재에 적합한 경화막 형성 조성물에 관한 것이다. 특히 본 발명은, 양의 유전이방성을 갖는 액정(△ε>0)이 충전된 IPS액정표시장치(In-plane Switching LCD; 면내 배향 스위칭LCD) 등의 액정표시장치(liquid crystal display; LCD)의 시야각특성이나, 유기 EL디스플레이의 반사방지막으로서 사용되는 원편광판의 시야각특성을 개선하기 위해 사용되는, +C플레이트(포지티브 C플레이트)를 제작하기에 유용한 경화막 형성 조성물, 배향재 및 위상차재에 관한 것이다.This invention relates to the cured film formation composition suitable for the vertical alignment material which orientates a liquid crystal molecule perpendicularly | vertically. In particular, the present invention relates to a liquid crystal display (LCD) such as an IPS liquid crystal display (In-plane Switching LCD) filled with a liquid crystal (Δε> 0) having positive dielectric anisotropy. A cured film forming composition, an alignment material and a phase difference material useful for producing a + C plate (positive C plate), which are used to improve the viewing angle characteristic or the viewing angle characteristic of a circular polarizing plate used as an antireflection film of an organic EL display. will be.
IPS-LCD는, 액정분자의 수직방향의 기울기가 발생하지 않으므로, 시야각에 의한 휘도변화/색변화가 적은 것이 특징인데, 콘트라스트비와 휘도, 응답속도를 높이기 어려운 점을 약점으로 들 수 있다. 예를 들어 특허문헌 1에 개시되는 바와 같이, 제안 초기의 IPS-LCD에서는, 시야각의 보상필름이 사용되고 있지 않으며, 이러한 시야각의 보상필름을 사용하지 않은 IPS-LCD에서는, 경사각의 암상태에 있어서의 상대적으로 큰 광누설로 인해, 낮은 콘트라스트비의 값을 나타낸다는 단점이 있다.IPS-LCD is characterized by low luminance change / color change due to the viewing angle because liquid crystal molecules are not inclined in the vertical direction. The weak point is that it is difficult to increase contrast ratio, luminance and response speed. For example, as disclosed in Patent Literature 1, in the IPS-LCD in the early stage of the proposal, a compensation film of the viewing angle is not used, and in the IPS-LCD without using such a compensation film of the viewing angle, in the dark state of the inclination angle. Due to the relatively large light leakage, there is a disadvantage in that it exhibits a low contrast ratio value.
특허문헌 2에는, +C플레이트와 +A플레이트(포지티브 A플레이트)를 사용한 IPS-LCD보상필름이 개시되어 있다. 본 문헌에는, 여기에 기재된 액정표시소자에 대하여, 이하의 구성이 나타나 있다.Patent Document 2 discloses an IPS-LCD compensating film using a + C plate and a + A plate (positive A plate). In this document, the following constitution is shown about the liquid crystal display element described here.
1) 액정층면에 평행한 전장을 인가할 수 있는 전극에 의해 공급되는 양 기판 사이에 수평배향을 갖는 액정층이 끼워져 있다.1) A liquid crystal layer having a horizontal orientation is sandwiched between both substrates supplied by an electrode capable of applying an electric field parallel to the surface of the liquid crystal layer.
2) 1매 이상의 +A플레이트와 +C플레이트가 양 편광판에 끼워져 있다.2) At least one + A plate and + C plate are inserted in both polarizers.
3) +A플레이트의 주광축은, 액정층의 주광축에 수직이다.3) The main optical axis of the + A plate is perpendicular to the main optical axis of the liquid crystal layer.
4) 액정층의 위상차값RLC, +C플레이트의 위상차값R+C, +A플레이트의 위상차값R+A는, 다음식을 만족하도록 결정된다.4) The phase difference value R LC of the liquid crystal layer, the phase difference value R + C of the + C plate, and the phase difference value R + A of the + A plate are determined to satisfy the following equation.
RLC:R+C:R+A≒1:0.5:0.25R LC : R + C : R + A ≒ 1: 0.5: 0.25
5) +A플레이트와 +C플레이트의 위상차값에 대해 편광판의 보호필름의 두께방향의 위상차값의 관계는 나타나 있지 않다(TAC, COP, PNB).5) The relationship between the phase difference value of the protective film of a polarizing plate with respect to the phase difference value of + A plate and + C plate is not shown (TAC, COP, PNB).
또한, 경사각에서의 암상태의 광누설을 최소화함으로써 정면 및 경사각에서의 높은 콘트라스트특성, 낮은 색변이(Color Shift)를 갖는 IPS-LCD를 제공하는 것을 목적으로 한, +A플레이트와 +C플레이트를 갖는 IPS-LCD가 개시되어 있다(특허문헌 3). 나아가, 유기 EL디스플레이의 반사방지막으로서 사용되는 원편광판의 시야각특성을 개선하기 위해, +C플레이트를 사용하는 제안도 이루어져 있다(특허문헌 5).In addition, the + A plate and the + C plate for the purpose of providing an IPS-LCD having high contrast characteristics and low color shift at the front and inclination angles by minimizing light leakage in the dark state at the inclination angle are provided. The IPS-LCD which has is disclosed (patent document 3). Furthermore, in order to improve the viewing angle characteristic of the circularly polarizing plate used as an antireflection film of an organic EL display, the proposal which uses + C plate is also made | formed (patent document 5).
종래 제안되어 있는 바와 같이, +C플레이트는 편광판의 시야각이 큰 부분에서의 광누설을 보상할 수 있으므로, IPS-LCD나, 유기 EL디스플레이의 반사방지막으로서 사용되는 원편광판의 광학보상필름으로서 매우 유용하다. 그러나, 종래 일반적으로 알려져 있는 연신처리에 의한 방법에서는, 수직배향(포지티브 C플레이트)성을 발현시키기 어렵다.As conventionally proposed, the + C plate can compensate for light leakage at a large viewing angle of the polarizing plate, and thus is very useful as an optical compensation film of an IPS-LCD or a circular polarizing plate used as an antireflection film of an organic EL display. Do. However, in the conventionally known stretching method, it is difficult to express vertical alignment (positive C plate).
또한, 종래 제안되어 있는 폴리이미드를 이용한 수직배향막은, 막 제작에 있어 N-메틸-2-피롤리돈 등의 폴리이미드의 용제를 사용할 필요가 있다. 그러므로 유리기재에서는 문제되지 않지만, 기재가 필름인 경우, 배향막 형성시에 기재에 데미지를 준다는 문제가 있다. 게다가, 폴리이미드를 이용한 수직배향막에서는, 고온에서의 소성이 필요해지고, 필름기재가 고온에 견딜 수 없다는 문제가 있다.In addition, the vertical alignment film using the polyimide proposed conventionally needs to use the solvent of polyimides, such as N-methyl- 2-pyrrolidone, in preparation of a film | membrane. Therefore, it does not matter in the glass substrate, but when the substrate is a film, there is a problem that damage the substrate at the time of forming the alignment film. In addition, in the vertical alignment film using polyimide, baking at a high temperature is required, and there is a problem that the film substrate cannot withstand high temperatures.
나아가, 장쇄알킬을 갖는 실란커플링제 등으로 기재를 직접 처리함으로써, 수직배향막을 형성하는 방법도 제안되어 있는데, 기재 표면에 하이드록시기가 존재하지 않는 경우에는 처리가 어려워, 기재가 제한된다는 문제가 있다(특허문헌 4).Furthermore, a method of forming a vertical alignment film by directly treating the substrate with a silane coupling agent having a long chain alkyl or the like has also been proposed. However, when a hydroxyl group is not present on the surface of the substrate, the treatment is difficult and the substrate is limited. (Patent Document 4).
최근에는 제조비용 저감의 요구에 따라, TAC(트리아세틸셀룰로오스)필름, COP(시클로올레핀폴리머)필름 등의 저가의 수지필름 상에서, 소위 롤투롤에 의해 생산되는 것이 요구되고 있다. 그러나, 상기 서술한 바와 같은 종래 재료로부터 형성된 배향막에서는, 수지필름 상에서 +C플레이트를 제조하는 것은 곤란했었다.In recent years, production of so-called roll-to-roll is required on low-cost resin films such as TAC (triacetylcellulose) film and COP (cycloolefin polymer) film in accordance with the demand for reduction of manufacturing cost. However, in the alignment film formed from the conventional material as mentioned above, it was difficult to manufacture + C plate on a resin film.
따라서, 밀착성이 우수하여 TAC필름 등의 수지필름 상에서도 고신뢰의 +C플레이트를 형성할 수 있는 배향재와, 이러한 배향재를 형성하기 위한 경화막 형성 조성물이 요구되고 있다.Therefore, the alignment material which is excellent in adhesiveness and which can form highly reliable + C plate also on resin films, such as a TAC film, and the cured film formation composition for forming such an alignment material are calculated | required.
본 발명은, 이상의 지견이나 검토결과에 기초하여 이루어진 것으로, 그 해결하고자 하는 과제는, 우수한 수직배향성을 가짐과 함께, 광학보상필름에 요구되는 투명성이나 용제내성을 구비하고, 나아가, 기재 및 중합성 액정층과의 밀착성을 구비하고, 수지필름 상에서도 저온단시간의 소성조건으로 안정되게 중합성 액정을 수직으로 배향시킬 수 있는 배향재를 제공하기 위한 경화막 형성 조성물을 제공하는 것이다.SUMMARY OF THE INVENTION The present invention has been made on the basis of the above findings and examination results. The problem to be solved is to have excellent vertical orientation and to have transparency and solvent resistance required for an optical compensation film, and to further improve the substrate and polymerizability. It is providing the cured film formation composition for providing the alignment material which has adhesiveness with a liquid crystal layer, and can also orientate a polymeric liquid crystal vertically stably under the baking conditions of low temperature short time also on a resin film.
그리고, 본 발명의 다른 목적은, 상기 경화막 형성 조성물로부터 얻어지며, 우수한 수직배향성과 밀착성을 구비함과 함께, 내용제성을 구비하고, 수지필름 상에서도 저온단시간의 소성조건으로 안정되게 중합성 액정을 수직으로 배향시킬 수 있는 배향재와 그 배향재를 이용하여 형성된 +C플레이트에 유용한 위상차재를 제공하는 것에 있다.In addition, another object of the present invention is obtained from the cured film-forming composition, has excellent vertical orientation and adhesiveness, has solvent resistance, and stably polymerizable liquid crystal on a resin film at low temperature and short time firing conditions. It is providing the orientation material which can be orientated perpendicularly | vertically, and the phase difference material useful for the + C plate formed using this orientation material.
본 발명의 다른 목적 및 이점은, 이하의 기재로부터 명백해 질 것이다.Other objects and advantages of the present invention will become apparent from the following description.
본 발명자들은 상기 목적을 달성하기 위해, 예의검토를 거듭한 결과, 수직배향성기와 C=C이중결합을 포함하는 중합성기를 갖는 폴리머를 베이스로 하는 경화막 형성재료를 선택함으로써, 우수한 수직배향성과 밀착성을 갖는 경화막을 형성할 수 있는 것을 발견하여, 본 발명을 완성시켰다.In order to achieve the above object, the present inventors have conducted extensive studies to select a cured film-forming material based on a polymer having a vertical alignment group and a polymerizable group including a C = C double bond, thereby providing excellent vertical alignment and adhesion. It discovered that the cured film which has a thing can be formed, and completed this invention.
즉, 본 발명은 제1 관점으로서,That is, the present invention is a first aspect,
(A)수직배향성기와 C=C이중결합을 포함하는 중합성기를 갖는 폴리머, 그리고 (A) a polymer having a vertically oriented group and a polymerizable group containing a C = C double bond, and
(B)라디칼중합개시제를 함유하는 경화막 형성 조성물로서,(B) A cured film formation composition containing a radical polymerization initiator,
상기 수직배향성기는 하기 식(1)로 표시되는 기인 것을 특징으로 하는, 경화막 형성 조성물에 관한 것이다.The said vertical orientation group is related with the cured film formation composition characterized by the group represented by following formula (1).
[화학식 1][Formula 1]
(식 [1] 중,(In formula [1],
Y1은 단결합 또는 결합기를 나타내고,Y 1 represents a single bond or a bonding group,
Y2는 단결합, 탄소원자수 1~15의 알킬렌기 혹은 -CH2-CH(OH)-CH2-를 나타내거나, 또는 벤젠환, 시클로헥산환 혹은 복소환으로부터 선택되는 2가의 환상기를 나타내고, 상기 환상기 상의 임의의 수소원자가, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있고,Y 2 represents a single bond, an alkylene group having 1 to 15 carbon atoms, or —CH 2 —CH (OH) —CH 2 —, or a divalent cyclic group selected from a benzene ring, a cyclohexane ring, or a hetero ring, Any hydrogen atom on the cyclic group is substituted with an alkyl group having 1 to 3 carbon atoms, an alkoxyl group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom May be,
Y3은 단결합 또는 탄소원자수 1~15의 알킬렌기를 나타내고,Y 3 represents a single bond or an alkylene group having 1 to 15 carbon atoms,
Y4는 단결합을 나타내거나, 또는 벤젠환, 시클로헥산환 혹은 복소환으로부터 선택되는 2가의 환상기, 또는 탄소원자수 17~30으로서 스테로이드골격을 갖는 2가의 유기기를 나타내고, 상기 환상기 상의 임의의 수소원자가, 하이드록시기, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있고,Y 4 represents a single bond or a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, or a divalent organic group having a steroid skeleton as 17 to 30 carbon atoms, and optionally Hydrogen atom may be substituted with a hydroxy group, an alkyl group having 1 to 3 carbon atoms, an alkoxyl group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom Maybe,
Y5는 벤젠환, 시클로헥산환 또는 복소환으로부터 선택되는 2가의 환상기를 나타내고, 이들 환상기 상의 임의의 수소원자가, 하이드록시기, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있고,Y 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on these cyclic groups is a hydroxy group, an alkyl group having 1 to 3 carbon atoms, or an alkoxyl group having 1 to 3 carbon atoms May be substituted with a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom,
n은 0~4의 정수를 나타내고, n이 2 이상인 경우, Y5끼리는 동일할 수도 상이할 수도 있고,n represents the integer of 0-4, and when n is 2 or more, Y <5> may be same or different,
Y6은 수소원자, 탄소원자수 1~18의 알킬기, 탄소원자수 1~18의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 또는 탄소원자수 1~18의 불소함유 알콕실기를 나타내고,Y 6 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxyl group having 1 to 18 carbon atoms or a fluorine-containing alkoxyl group having 1 to 18 carbon atoms,
Y2 및 Y3에 있어서의 알킬렌기, 그리고, 상기 환상기 상의 치환기 및 Y6에 있어서의 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 직쇄상, 분지상, 혹은 환상 중 어느 하나 또는 이들의 조합일 수도 있고,The alkylene group in Y 2 and Y 3 , and the substituent on the cyclic group and the alkyl group, fluorine-containing alkyl group, alkoxyl group and fluorine-containing alkoxyl group in Y 6 are either linear, branched or cyclic. Or a combination thereof,
또한 Y2 및 Y3에 있어서의 알킬렌기, 그리고, Y6에 있어서의 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 결합기끼리가 서로 이웃하지 않는 한 1 내지 3의 결합기로 중단되어 있을 수도 있고,In addition, the alkylene group for Y 2 and Y 3 , and the alkyl group, fluorine-containing alkyl group, alkoxyl group and fluorine-containing alkoxyl group for Y 6 are interrupted by a bond of 1 to 3 unless the bonding groups are adjacent to each other. Maybe
나아가 Y2, Y4 혹은 Y5가 2가의 환상기를 나타내거나, 또는 Y4가 스테로이드골격을 갖는 2가의 유기기를 나타내거나, 또는 Y2가 -CH2-CH(OH)-CH2-를 나타내거나, 또는 Y2 혹은 Y3이 알킬렌기를 나타내거나, 또는 Y6이 알킬기 혹은 불소함유 알킬기를 나타낼 때, 이 2가의 환상기, 이 스테로이드골격을 갖는 2가의 유기기, 이 -CH2-CH(OH)-CH2-, 이 알킬렌기, 이 알킬기 및 이 불소함유 알킬기는, 이것들에 인접하는 기와 결합기를 개재하여 결합하고 있을 수도 있고,Furthermore, Y 2 , Y 4 or Y 5 represents a divalent cyclic group, Y 4 represents a divalent organic group having a steroid skeleton, or Y 2 represents -CH 2 -CH (OH) -CH 2-. Or when Y 2 or Y 3 represents an alkylene group, or Y 6 represents an alkyl group or a fluorine-containing alkyl group, the divalent cyclic group, the divalent organic group having the steroid skeleton, the -CH 2 -CH (OH) —CH 2 —, this alkylene group, this alkyl group and this fluorine-containing alkyl group may be bonded via a group and a bonding group adjacent to these,
그리고 상기 결합기는, -O-, -CH2O-, -COO-, -OCO-, -NHCO-, -NH-CO-O- 및 -NH-CO-NH-로 이루어지는 군으로부터 선택되는 기를 나타내고,And the linking group represents a group selected from the group consisting of -O-, -CH 2 O-, -COO-, -OCO-, -NHCO-, -NH-CO-O-, and -NH-CO-NH-. ,
단, Y2 내지 Y6이 각각 나타내는 바의 단결합, 탄소원자수 1~15의 알킬렌기, 벤젠환, 시클로헥산환, 복소환, 스테로이드골격을 갖는 2가의 유기기, -CH2-CH(OH)-CH2-, 탄소원자수 1~18의 알킬기, 탄소원자수 1~18의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 및 탄소원자수 1~18의 불소함유 알콕실기의 탄소원자수의 합계는 6~30이다).Provided that each of Y 2 to Y 6 represents a single bond, an alkylene group having 1 to 15 carbon atoms, a benzene ring, a cyclohexane ring, a heterocycle, a divalent organic group having a steroid skeleton, -CH 2 -CH (OH ) -CH 2 -, the sum of carbon atoms of 1 to 18 alkyl group, a carbon atom number of 1 to 18 fluorinated alkyl group, a carbon atom number of 1 to 18 carbon atoms and an alkoxyl group of 1 to 18 carbon atoms, a fluorine-containing alkoxyl group of the 6 ~ 30).
제2 관점으로서, (A)성분의 폴리머에 있어서, C=C이중결합을 포함하는 중합성기가, 아크릴기, 메타크릴기, 비닐기, 알릴기 및 말레이미드기로 이루어지는 군으로부터 선택되는 적어도 1종인, 제1 관점에 기재된 경화막 형성 조성물에 관한 것이다.As a 2nd viewpoint, in the polymer of (A) component, the polymeric group containing C = C double bond is at least 1 sort (s) chosen from the group which consists of an acryl group, a methacryl group, a vinyl group, an allyl group, and a maleimide group. It relates to the cured film formation composition as described in a 1st viewpoint.
제3 관점으로서, (C)C=C이중결합을 포함하는 중합성기를 갖는 모노머 및 폴리머로 이루어지는 군으로부터 선택되는 적어도 1종을 추가로 함유하는, 제1 관점 또는 제2 관점에 기재된 경화막 형성 조성물에 관한 것이다.As a 3rd viewpoint, the cured film formation as described in a 1st viewpoint or a 2nd viewpoint which further contains at least 1 sort (s) chosen from the group which consists of a monomer and a polymer which have a polymerizable group containing a (C) C = C double bond. It relates to a composition.
제4 관점으로서, (A)성분 100질량부에 기초하여, 0.1질량부~50질량부의 (B)성분을 함유하는, 제1 관점 내지 제3 관점 중 어느 하나에 기재된 경화막 형성 조성물에 관한 것이다.As a 4th viewpoint, it is related with the cured film formation composition in any one of a 1st viewpoint thru | or a 3rd viewpoint which contains 0.1 mass part-50 mass parts (B) component based on 100 mass parts of (A) component. .
제5 관점으로서, (A)성분의 100질량부에 기초하여, 10질량부 내지 1000질량부의 (C)성분을 함유하는, 제3 관점 또는 제4 관점에 기재된 경화막 형성 조성물에 관한 것이다.As a 5th viewpoint, based on 100 mass parts of (A) component, it is related with the cured film formation composition as described in a 3rd viewpoint or a 4th viewpoint containing 10 mass parts-1000 mass parts (C) component.
제6 관점으로서, 제1 관점 내지 제5 관점 중 어느 하나에 기재된 경화막 형성 조성물을 경화시켜 얻어지는 것을 특징으로 하는 배향재에 관한 것이다.As a 6th viewpoint, it is obtained by hardening | curing the cured film formation composition in any one of a 1st viewpoint thru | or a 5th viewpoint, It is related with the orientation material characterized by the above-mentioned.
제7 관점으로서, 제1 관점 내지 제5 관점 중 어느 하나에 기재된 경화막 형성 조성물로부터 얻어지는 경화막을 사용하여 형성되는 것을 특징으로 하는 위상차재에 관한 것이다.As a 7th viewpoint, it is formed using the cured film obtained from the cured film formation composition in any one of a 1st viewpoint thru | or a 5th viewpoint, It is related with the phase difference material characterized by the above-mentioned.
본 발명의 제1의 태양에 따르면, 우수한 수직배향성을 구비하고, 수지필름 상에서도 저온단시간의 소성조건으로 안정되게 중합성 액정을 수직배향시킬 수 있는 배향재를 제공하기 위해 유용한 경화막 형성 조성물을 제공할 수 있다.According to the first aspect of the present invention, there is provided a cured film-forming composition which has excellent vertical alignment and is useful for providing an alignment material capable of vertically aligning a polymerizable liquid crystal stably under low-temperature and short firing conditions even on a resin film. can do.
본 발명의 제2의 태양에 따르면, 우수한 수직배향성을 구비하고, 저온단시간의 소성조건으로 안정되게 중합성 액정을 수직배향시킬 수 있는 배향재를 제공할 수 있다.According to the second aspect of the present invention, it is possible to provide an alignment material having excellent vertical alignment and capable of stably vertically polymerizing the liquid crystal under low temperature and short firing conditions.
본 발명의 제3의 태양에 따르면, 수지필름 상에서도 높은 효율로 형성할 수 있고, 고투명이고 높은 용제내성과 기판 및 액정필름과의 밀착성을 갖는 위상차재를 제공할 수 있다.According to the third aspect of the present invention, a phase difference material which can be formed on a resin film with high efficiency and has high transparency and high solvent resistance and adhesion to a substrate and a liquid crystal film can be provided.
<경화막 형성 조성물><Cured film forming composition>
본 발명의 경화막 형성 조성물은, (A)성분인 수직배향성기와 C=C이중결합을 포함하는 중합성기를 갖는 폴리머, 및 (B)성분인 라디칼중합개시제를 함유한다. 본 발명의 경화막 형성 조성물은, 상기 (A)성분 및 (B)성분에 더하여, 추가로, (C)성분으로서 C=C이중결합을 포함하는 중합성기를 갖는 모노머 및 폴리머로 이루어지는 군으로부터 선택되는 적어도 1종 또한 함유할 수 있다. 그리고, 본 발명의 효과를 손상시키지 않는 한, 기타 첨가제를 함유할 수 있다.The cured film formation composition of this invention contains the polymer which has a vertical orientation group which is (A) component, and a polymerizable group containing C = C double bond, and the radical polymerization initiator which is (B) component. In addition to the said (A) component and (B) component, the cured film formation composition of this invention is further selected from the group which consists of a monomer and polymer which have a polymeric group containing C = C double bond as (C) component. It may also contain at least one. And other additives can be contained as long as the effect of this invention is not impaired.
이하, 각 성분의 상세를 설명한다.Hereinafter, the detail of each component is demonstrated.
<(A)성분><(A) component>
본 발명의 경화막 형성 조성물에 함유되는 (A)성분은, 수직배향성기와 C=C이중결합을 포함하는 중합성기를 갖는 폴리머이다.(A) component contained in the cured film formation composition of this invention is a polymer which has a polymerizable group containing a vertical orientation group and C = C double bond.
본 명세서에 있어서, 수직배향성기란, 예를 들어 탄소원자수가 6~30 정도인 탄화수소기를 포함하는 기를 나타내고, 구체적으로는 후술하는 식 [1]로 표시되는 기를 나타낸다.In the present specification, the vertically oriented group represents, for example, a group containing a hydrocarbon group having about 6 to 30 carbon atoms, and specifically, a group represented by Formula [1] described later.
따라서, 수직배향성기를 갖는 모노머로서, 예를 들어 탄소원자수 6~30 정도의 탄화수소기를 갖는 모노머를 들 수 있다. 탄소원자수 6~30의 탄화수소기로는, 직쇄상, 분지상 혹은 환상의 탄소원자수 6~30의 알킬기 또는 방향족기를 포함하는 탄소원자수 6~30의 탄화수소기를 들 수 있다. 따라서 탄소원자수 6~30의 탄화수소기를 포함하는 모노머의 구체예로는, 아크릴산의 알킬에스테르, 메타크릴산의 알킬에스테르, 알킬비닐에테르, 2-알킬스티렌, 3-알킬스티렌, 4-알킬스티렌, N-알킬말레이미드로서, 해당 알킬기가 탄소원자수 6~30인 것이나, 이들 모노머의 알킬기가 상기의 탄소원자수가 6~30인 방향족기를 포함하는 탄소원자수 6~30의 탄화수소기로 치환된 것을 들 수 있다.Therefore, as a monomer which has a vertically oriented group, the monomer which has a hydrocarbon group of about 6-30 carbon atoms is mentioned, for example. Examples of the hydrocarbon group having 6 to 30 carbon atoms include a hydrocarbon group having 6 to 30 carbon atoms including a linear, branched or cyclic alkyl group having 6 to 30 carbon atoms or an aromatic group. Therefore, as a specific example of the monomer containing a C6-C30 hydrocarbon group, the alkyl ester of acrylic acid, the alkyl ester of methacrylic acid, the alkyl vinyl ether, 2-alkylstyrene, 3-alkylstyrene, 4-alkylstyrene, N Examples of the alkylmaleimide include those wherein the alkyl group has 6 to 30 carbon atoms, or the alkyl group of these monomers is substituted with a hydrocarbon group having 6 to 30 carbon atoms containing an aromatic group having 6 to 30 carbon atoms.
수직배향성기는, 보다 구체적으로는, 하기 식 [1]로 표시되는 기이다.More specifically, the vertical alignment group is a group represented by the following formula [1].
[화학식 2][Formula 2]
식 [1] 중, Y1은 단결합 또는 결합기를 나타낸다.In formula [1], Y <1> represents a single bond or a bonding group.
식 [1] 중, Y2는 단결합, 탄소원자수 1~15의 알킬렌기 또는 -CH2-CH(OH)-CH2-를 나타낸다.Formula [1], Y 2 is a single bond, carbon atom number of from 1 to 15 alkylene group or -CH 2 -CH (OH) -CH 2 - represents an.
또한 Y2로서, 벤젠환, 시클로헥산환 또는 복소환으로부터 선택되는 2가의 환상기를 들 수 있고, 이들 환상기 상의 임의의 수소원자는, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있다.Moreover, as Y <2> , the bivalent cyclic group chosen from a benzene ring, a cyclohexane ring, or a heterocyclic ring is mentioned, Arbitrary hydrogen atoms on these cyclic groups are a C1-C3 alkyl group and C1-C3 alkoxy It may be substituted by a real group, a C1-C3 fluorine-containing alkyl group, a C1-C3 fluorine-containing alkoxyl group, or a fluorine atom.
상기 복소환으로는 피롤환, 이미다졸환, 옥사졸환, 티아졸환, 피라졸환, 피리딘환, 피리미딘환, 퀴놀린환, 피라졸린환, 이소퀴놀린환, 카바졸환, 퓨린환, 티아디아졸환, 피리다진환, 피라졸린환, 트리아진환, 피라졸리딘환, 트리아졸환, 피라진환, 벤즈이미다졸환, 신놀린환, 페난트롤린환, 인돌환, 퀴녹살린환, 벤조티아졸환, 페노티아진환, 옥사디아졸환, 아크리딘환 등을 들 수 있으며, 보다 바람직한 것은, 피롤환, 이미다졸환, 피라졸환, 피리딘환, 피리미딘환, 피라졸린환, 카바졸환, 피리다진환, 피라졸린환, 트리아진환, 피라졸리딘환, 트리아졸환, 피라진환, 벤즈이미다졸환이다.Examples of the hetero ring include pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring and pyri Diazine ring, pyrazoline ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, cinnoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadia A sol ring, an acridine ring, etc. are mentioned, More preferably, a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a pyrazoline ring, a carbazole ring, a pyridazine ring, a pyrazoline ring, a triazine ring, Pyrazolidine ring, triazole ring, pyrazine ring, and benzimidazole ring.
상기 치환기로서 언급한 알킬기로는, 메틸기, 에틸기, n-프로필기, 이소프로필기, 시클로프로필기를 들 수 있고, 상기 알콕실기로는, 상기 알킬기의 구체예로서 언급한 기에 산소원자-O-가 결합한 기를 들 수 있다. 또한 상기 불소함유 알킬기, 불소함유 알콕실기로는, 상기 알킬기 및 알콕실기 중 임의의 수소원자가 불소원자로 치환된 기를 들 수 있다.Examples of the alkyl group mentioned as the substituent include methyl group, ethyl group, n-propyl group, isopropyl group and cyclopropyl group. As the alkoxyl group, oxygen atom-O- is added to the group mentioned as a specific example of the alkyl group. The combined group is mentioned. Examples of the fluorine-containing alkyl group and fluorine-containing alkoxyl group include groups in which any hydrogen atom of the alkyl group and alkoxyl group is substituted with a fluorine atom.
이들 중에서도, 합성의 용이함의 점으로부터, Y2는 단결합, 탄소원자수 1~15의 알킬렌기, 또는 벤젠환 혹은 시클로헥산환으로부터 선택되는 2가의 환상기인 것이 바람직하다.Among these, from the point of ease of synthesis, Y 2 is preferably a divalent cyclic group selected from a single bond, an alkylene group having 1 to 15 carbon atoms, or a benzene ring or a cyclohexane ring.
상기 식 [1] 중, Y3은 단결합 또는 탄소원자수 1~15의 알킬렌기를 나타낸다.In said formula [1], Y <3> represents a single bond or an alkylene group of 1-15 carbon atoms.
상기 식 [1] 중, Y4는 단결합을 나타내거나, 또는 벤젠환, 시클로헥산환 혹은 복소환으로부터 선택되는 2가의 환상기를 나타내고, 이들 환상기 상의 임의의 수소원자가, 하이드록시기, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있다.In said formula [1], Y <4> represents a single bond or shows the bivalent cyclic group chosen from a benzene ring, a cyclohexane ring, or a heterocyclic ring, and the arbitrary hydrogen atoms on these cyclic groups are a hydroxyl group and a carbon atom number. It may be substituted with an alkyl group having 1 to 3, an alkoxyl group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom.
상기 복소환 그리고 치환기로서 언급한 알킬기 등은, 상기 서술한 Y2에서 언급한 것으로 할 수 있다.The heterocyclic group and the alkyl group mentioned as the substituent may be those mentioned for Y 2 described above.
나아가, Y4로서, 탄소원자수 17~30으로서 스테로이드골격을 갖는 2가의 유기기일 수도 있다. 그 바람직한 예는, 콜레스테릴, 앤드로스테릴, β-콜레스테릴, 에피앤드로스테릴, 에리고스테릴, 에스트릴, 11α-하이드록시메틸스테릴, 11α-프로게스테릴, 라노스테릴, 멜라트라닐, 메틸테스트로스테릴, 노레티스테릴, 프레그네노닐, β-시토스테릴, 스티그마스테릴, 테스토스테릴, 및 아세트산콜레스테롤에스테르 등으로부터 선택되는 구조로부터 수소원자를 2개 제거한 구조를 갖는 2가의 기이다. 보다 구체적으로는, 예를 들어 하기와 같다.Further, as Y 4 , a divalent organic group having a steroid skeleton with 17 to 30 carbon atoms may be used. Preferred examples thereof are cholesteryl, andostereryl, β-cholesteryl, epiandrosteryl, erygosteryl, estryl, 11α-hydroxymethylsteryl, 11α-progesteryl, la Hydrogen atom from a structure selected from nosteryl, melatranyl, methyl testosteryl, norresteryl, pregnnonyl, β-sitosteryl, stigmasteryl, testosteryl, and cholesterol acetate, and the like. It is a bivalent group which has a structure which removed dog. More specifically, it is as follows, for example.
[화학식 3][Formula 3]
(식 중, *는 결합위치를 나타낸다.)(Wherein * represents a bonding position)
이들 중에서도, 합성의 용이함의 점으로부터, Y4는 단결합, 벤젠환 혹은 시클로헥산환으로부터 선택되는 2가의 환상기 또는 탄소원자수 17~30으로서 스테로이드골격을 갖는 2가의 유기기인 것이 바람직하다.Among them, from the viewpoint of ease of synthesis, Y 4 is preferably a divalent cyclic group selected from a single bond, a benzene ring or a cyclohexane ring or a divalent organic group having a steroid skeleton as 17 to 30 carbon atoms.
식 [1] 중, Y5는 벤젠환, 시클로헥산환 또는 복소환으로부터 선택되는 2가의 환상기를 나타내고, 이들 환상기 상의 임의의 수소원자가, 하이드록시기, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있다. 상기 복소환 그리고 치환기로서 언급한 알킬기 등은, 상기 서술한 Y4에서 언급한 것으로 할 수 있다.In formula [1], Y <5> represents the bivalent cyclic group chosen from a benzene ring, a cyclohexane ring, or a heterocyclic ring, and arbitrary hydrogen atoms on these cyclic groups are a hydroxyl group, an alkyl group of 1-3 carbon atoms, and a carbon atom number It may be substituted by the alkoxyl group of 1-3, the fluorine-containing alkyl group of 1-3 carbon atoms, the fluorine-containing alkoxyl group of 1-3 carbon atoms, or fluorine atom. The heterocyclic group and the alkyl group mentioned as the substituent may be those mentioned for Y 4 described above.
이들 중에서도, Y5는 벤젠환 또는 시클로헥산환으로부터 선택되는 2가의 환상기인 것이 바람직하다.Among these, Y 5 is preferably a divalent cyclic group selected from a benzene ring or a cyclohexane ring.
또한 식 [1] 중, n은 0~4의 정수를 나타내고, n이 2 이상인 경우, Y5끼리는 동일한 기일 수도 상이한 기일 수도 있다. 이 중에서도, 원료의 입수성이나 합성의 용이함의 점으로부터, n은 0~3이 바람직하다. 보다 바람직한 것은, 0~2이다.In addition, in formula [1], n represents the integer of 0-4, and when n is two or more, Y <5> may be the same group or different group. Among these, 0-3 are preferable n from the point of availability of a raw material, and the ease of synthesis. More preferably, it is 0-2.
식 [1] 중, Y6은 수소원자, 탄소원자수 1~18의 알킬기, 탄소원자수 1~18의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 또는 탄소원자수 1~18의 불소함유 알콕실기를 나타낸다.In formula [1], Y <6> is a hydrogen atom, the C1-C18 alkyl group, the C1-C18 fluorine-containing alkyl group, the C1-C18 alkoxyl group, or the C1-C18 fluorine-containing alkoxyl group Indicates.
이 중에서도, Y6은 탄소원자수 1~18의 알킬기, 탄소원자수 1~10의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 또는 탄소원자수 1~10의 불소함유 알콕실기인 것이 바람직하다. 보다 바람직하게는, Y6은 탄소원자수 1~17의 알킬기 또는 탄소원자수 1~17의 알콕실기이다. 특히 바람직하게는, Y6은 탄소원자수 1~16의 알킬기 또는 탄소원자수 1~16의 알콕실기이다.Among these, Y 6 is preferably an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, an alkoxyl group having 1 to 18 carbon atoms, or a fluorine-containing alkoxyl group having 1 to 10 carbon atoms. More preferably, Y 6 is an alkyl group having 1 to 17 carbon atoms or an alkoxyl group having 1 to 17 carbon atoms. Especially preferably, Y 6 is a C1-C16 alkyl group or a C1-C16 alkoxyl group.
한편, Y4가 스테로이드골격을 갖는 2가의 유기기인 경우는, Y6은 수소원자인 것이 바람직하다.On the other hand, when Y 4 is a divalent organic group having a steroid skeleton, Y 6 is preferably a hydrogen atom.
상기 식 [1] 중의 정의에 있어서 언급한 알킬렌기, 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 직쇄상, 분지상, 혹은 환상 중 어느 하나 또는 이들의 조합일 수도 있다.The alkylene group, alkyl group, fluorine-containing alkyl group, alkoxyl group, and fluorine-containing alkoxyl group mentioned in the definition in the formula [1] may be any one of linear, branched, or cyclic or a combination thereof.
상기 알킬기는, 예를 들어, 메틸기, 에틸기, n-프로필기, 이소프로필기, n-부틸기, 이소부틸기, sec-부틸기, tert-부틸기, n-펜틸기, 1-메틸-n-부틸기, 2-메틸-n-부틸기, 3-메틸-n-부틸기, 1,1-디메틸-n-프로필기, 1,2-디메틸-n-프로필기, 2,2-디메틸-n-프로필기, 1-에틸-n-프로필기, n-헥실기, 1-메틸-n-펜틸기, 2-메틸-n-펜틸기, 3-메틸-n-펜틸기, 4-메틸-n-펜틸기, 1,1-디메틸-n-부틸기, 1,2-디메틸-n-부틸기, 1,3-디메틸-n-부틸기, 2,2-디메틸-n-부틸기, 2,3-디메틸-n-부틸기, 3,3-디메틸-n-부틸기, 1-에틸-n-부틸기, 2-에틸-n-부틸기, 1,1,2-트리메틸-n-프로필기, 1,2,2-트리메틸-n-프로필기, 1-에틸-1-메틸-n-프로필기, 1-에틸-2-메틸-n-프로필기, n-헵틸기, 1-메틸-n-헥실기, 2-메틸-n-헥실기, 3-메틸-n-헥실기, 1,1-디메틸-n-펜틸기, 1,2-디메틸-n-펜틸기, 1,3-디메틸-n-펜틸기, 2,2-디메틸-n-펜틸기, 2,3-디메틸-n-펜틸기, 3,3-디메틸-n-펜틸기, 1-에틸-n-펜틸기, 2-에틸-n-펜틸기, 3-에틸-n-펜틸기, 1-메틸-1-에틸-n-부틸기, 1-메틸-2-에틸-n-부틸기, 1-에틸-2-메틸-n-부틸기, 2-메틸-2-에틸-n-부틸기, 2-에틸-3-메틸-n-부틸기, n-옥틸기, 1-메틸-n-헵틸기, 2-메틸-n-헵틸기, 3-메틸-n-헵틸기, 1,1-디메틸-n-헥실기, 1,2-디메틸-n-헥실기, 1,3-디메틸-n-헥실기, 2,2-디메틸-n-헥실기, 2,3-디메틸-n-헥실기, 3,3-디메틸-n-헥실기, 1-에틸-n-헥실기, 2-에틸-n-헥실기, 3-에틸-n-헥실기, 1-메틸-1-에틸-n-펜틸기, 1-메틸-2-에틸-n-펜틸기, 1-메틸-3-에틸-n-펜틸기, 2-메틸-2-에틸-n-펜틸기, 2-메틸-3-에틸-n-펜틸기, 3-메틸-3-에틸-n-펜틸기, n-노닐기, n-데실기, n-운데실기, n-도데실기, n-트리데실기, n-테트라데실기, n-펜타데실기 등을 들 수 있다. The alkyl group is, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-pentyl group, 1-methyl-n -Butyl group, 2-methyl-n-butyl group, 3-methyl-n-butyl group, 1,1-dimethyl-n-propyl group, 1,2-dimethyl-n-propyl group, 2,2-dimethyl- n-propyl group, 1-ethyl-n-propyl group, n-hexyl group, 1-methyl-n-pentyl group, 2-methyl-n-pentyl group, 3-methyl-n-pentyl group, 4-methyl- n-pentyl group, 1,1-dimethyl-n-butyl group, 1,2-dimethyl-n-butyl group, 1,3-dimethyl-n-butyl group, 2,2-dimethyl-n-butyl group, 2 , 3-dimethyl-n-butyl group, 3,3-dimethyl-n-butyl group, 1-ethyl-n-butyl group, 2-ethyl-n-butyl group, 1,1,2-trimethyl-n-propyl Group, 1,2,2-trimethyl-n-propyl group, 1-ethyl-1-methyl-n-propyl group, 1-ethyl-2-methyl-n-propyl group, n-heptyl group, 1-methyl- n-hexyl group, 2-methyl-n-hexyl group, 3-methyl-n-hexyl group, 1,1-dimethyl-n-pentyl group, 1,2-dimethyl-n-pentyl group, 1,3-dimethyl -n-pentyl group, 2,2-dimethyl-n-pentyl group, 2,3-dimethyl-n-pent Tyl group, 3,3-dimethyl-n-pentyl group, 1-ethyl-n-pentyl group, 2-ethyl-n-pentyl group, 3-ethyl-n-pentyl group, 1-methyl-1-ethyl-n- Butyl group, 1-methyl-2-ethyl-n-butyl group, 1-ethyl-2-methyl-n-butyl group, 2-methyl-2-ethyl-n-butyl group, 2-ethyl-3-methyl- n-butyl group, n-octyl group, 1-methyl-n-heptyl group, 2-methyl-n-heptyl group, 3-methyl-n-heptyl group, 1,1-dimethyl-n-hexyl group, 1, 2-dimethyl-n-hexyl group, 1,3-dimethyl-n-hexyl group, 2,2-dimethyl-n-hexyl group, 2,3-dimethyl-n-hexyl group, 3,3-dimethyl-n- Hexyl group, 1-ethyl-n-hexyl group, 2-ethyl-n-hexyl group, 3-ethyl-n-hexyl group, 1-methyl-1-ethyl-n-pentyl group, 1-methyl-2-ethyl -n-pentyl group, 1-methyl-3-ethyl-n-pentyl group, 2-methyl-2-ethyl-n-pentyl group, 2-methyl-3-ethyl-n-pentyl group, 3-methyl-3 -Ethyl-n-pentyl group, n-nonyl group, n-decyl group, n-undecyl group, n-dodecyl group, n-tridecyl group, n- tetradecyl group, n-pentadecyl group, etc. are mentioned. .
상기 알킬렌기로는, 상기 알킬기로부터 임의의 수소원자를 1개 제거한 2가의 기를 들 수 있다.As said alkylene group, the bivalent group remove | excluding one arbitrary hydrogen atom from the said alkyl group is mentioned.
상기 알콕실기로는, 상기 알킬기의 구체예로서 언급한 기에 산소원자-O-가 결합한 기를 들 수 있다.As said alkoxyl group, group which oxygen atom -O- couple | bonded with the group mentioned as a specific example of the said alkyl group is mentioned.
또한 상기 불소함유 알킬기, 불소함유 알콕실기로는, 상기 알킬기 및 알콕실기 중 임의의 수소원자가 불소원자로 치환된 기를 들 수 있다.Examples of the fluorine-containing alkyl group and fluorine-containing alkoxyl group include groups in which any hydrogen atom of the alkyl group and alkoxyl group is substituted with a fluorine atom.
상기 Y2 및 Y3에 있어서의 알킬렌기, 그리고, 상기 환상기 상의 치환기 및 Y6에 있어서의 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 직쇄상, 분지상, 혹은 환상 중 어느 하나 또는 이들의 조합일 수도 있다.The alkylene group in Y 2 and Y 3 , and the substituent on the cyclic group and the alkyl group, fluorine-containing alkyl group, alkoxyl group and fluorine-containing alkoxyl group in Y 6 may be linear, branched or cyclic. It may be one or a combination thereof.
또한, Y2 및 Y3에 있어서의 알킬렌기, 그리고, Y6에 있어서의 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 결합기끼리가 서로 이웃하지 않는 한 1 내지 3의 결합기로 중단되어 있을 수도 있다.In addition, the alkylene group in Y <2> and Y <3> , and the alkyl group, fluorine-containing alkyl group, alkoxyl group, and fluorine-containing alkoxyl group in Y <6> are interrupted by the coupling groups of 1-3 unless bond groups adjoin each other. It may be.
나아가, Y2, Y4 혹은 Y5가 2가의 환상기를 나타내거나, 또는 Y4가 스테로이드골격을 갖는 2가의 유기기를 나타내거나, 또는 Y2가 -CH2-CH(OH)-CH2-를 나타내거나, 또는 Y2 혹은 Y3이 알킬렌기를 나타내거나, 또는 Y6이 알킬기 혹은 불소함유 알킬기를 나타낼 때, 이 2가의 환상기, 이 스테로이드골격을 갖는 2가의 유기기, 이 -CH2-CH(OH)-CH2-, 이 알킬렌기, 이 알킬기 및 이 불소함유 알킬기는, 이것들에 인접하는 기와 결합기를 개재하여 결합하고 있을 수도 있다.Furthermore, Y 2 , Y 4 or Y 5 represents a divalent cyclic group, Y 4 represents a divalent organic group having a steroid skeleton, or Y 2 represents -CH 2 -CH (OH) -CH 2- . Or when Y 2 or Y 3 represents an alkylene group, or Y 6 represents an alkyl group or a fluorine-containing alkyl group, the divalent cyclic group, the divalent organic group having the steroid skeleton, the -CH 2- CH (OH) —CH 2 —, this alkylene group, this alkyl group and this fluorine-containing alkyl group may be bonded via a group adjacent to these and a bonding group.
또한 상기 결합기는, -O-, -CH2O-, -CO-, -COO-, -OCO-, -NHCO-, -CONH-, -NH-CO-O-, -O-CO-NH- 및 -NH-CO-NH-로 이루어지는 군으로부터 선택되는 기를 나타낸다.In addition, the bond group is -O-, -CH 2 O-, -CO-, -COO-, -OCO-, -NHCO-, -CONH-, -NH-CO-O-, -O-CO-NH- And -NH-CO-NH-.
한편, Y2 내지 Y6이 각각 나타내는 바의 단결합, 탄소원자수 1~15의 알킬렌기, 벤젠환, 시클로헥산환, 복소환, 스테로이드골격을 갖는 2가의 유기기, -CH2-CH(OH)-CH2-, 탄소원자수 1~18의 알킬기, 탄소원자수 1~18의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 및 탄소원자수 1~18의 불소함유 알콕실기의 탄소원자수의 합계는 6~30이고, 예를 들어 6~20이다.On the other hand, Y 2 to Y 6 each represent a single bond, an alkylene group having 1 to 15 carbon atoms, a benzene ring, a cyclohexane ring, a heterocycle, a divalent organic group having a steroid skeleton, -CH 2 -CH (OH ) -CH 2 -, the sum of carbon atoms of 1 to 18 alkyl group, a carbon atom number of 1 to 18 fluorinated alkyl group, a carbon atom number of 1 to 18 carbon atoms and an alkoxyl group of 1 to 18 carbon atoms, a fluorine-containing alkoxyl group of the 6 -30, for example, 6-20.
이들 중, 수직배향성과 중합성 액정의 도포성을 고려할 때, 수직배향성기는, 탄소원자수 7~18, 특히 8~16의 알킬기를 포함하는 기인 것이 바람직하다.Among these, in consideration of the vertical alignment property and the applicability of the polymerizable liquid crystal, the vertical alignment group is preferably a group containing an alkyl group having 7 to 18 carbon atoms, particularly 8 to 16 carbon atoms.
(A)성분의 폴리머에 있어서, C=C이중결합을 포함하는 중합성기로는, 아크릴기, 메타크릴기, 비닐기, 알릴기 및 말레이미드기 등을 들 수 있다.In the polymer of (A) component, an acryl group, a methacryl group, a vinyl group, an allyl group, a maleimide group, etc. are mentioned as a polymeric group containing C = C double bond.
상기 C=C이중결합을 포함하는 중합성기는 폴리머의 주골격의 측쇄에 편입될 수 있고, 즉, C=C이중결합을 포함하는 중합성기를 갖는 특정 측쇄로서, (A)성분의 폴리머의 측쇄에 편입될 수 있다.The polymerizable group including the C = C double bond may be incorporated into the side chain of the main skeleton of the polymer, that is, the specific side chain having the polymerizable group including the C═C double bond, and the side chain of the polymer of (A) component. It can be incorporated into.
(A)성분의 폴리머에 있어서, 상기 C=C이중결합을 포함하는 중합성기를 갖는 특정 측쇄는, 탄소원자수가 3~16으로서, 말단에 불포화결합을 갖는 것인 것이 바람직하고, 식(b2)로 표시되는 특정 측쇄가 특히 바람직하다.In the polymer of (A) component, it is preferable that the specific side chain which has a polymeric group containing the said C = C double bond has 3-16 carbon atoms, and has an unsaturated bond at the terminal, Formula (b2) Particular preference is given to specific side chains represented by.
[화학식 4][Formula 4]
식(b2) 중, R51은, 탄소원자수가 1~14이고, 지방족기, 환식 구조를 포함하는 지방족기 및 방향족기로 이루어지는 군으로부터 선택되는 2가의 유기기, 또는, 이 군으로부터 선택되는 복수의 2가의 유기기의 조합으로 이루어지는 2가의 유기기이다. R51은, 에스테르결합, 에테르결합, 아미드결합, -CH2CH(OH)CH2-결합 또는 우레탄결합 등을 포함하고 있을 수도 있다.In formula (b2), R 51 is a divalent organic group selected from the group consisting of an aliphatic group containing 1 to 14 carbon atoms, an aliphatic group containing a cyclic structure, and an aromatic group, or a plurality of selected from this group. It is a bivalent organic group which consists of a combination of bivalent organic group. R 51 may contain an ester bond, an ether bond, an amide bond, a —CH 2 CH (OH) CH 2 — bond or a urethane bond.
식(b2)에 있어서, R52는 수소원자 또는 메틸기이고, R52가 수소원자인 특정 측쇄가 바람직하고, 보다 바람직하게는, 말단이 아크릴로일기, 메타크릴로일기 또는 스티릴기인 특정 측쇄이다.In formula (b2), R 52 is a hydrogen atom or a methyl group, and the specific side chain which R 52 is a hydrogen atom is preferable, More preferably, it is a specific side chain whose terminal is an acryloyl group, a methacryloyl group, or a styryl group. .
본 발명의 (A)성분의 폴리머를 얻는 방법은, 특별히 한정되지 않는다. 예를 들어, 미리 라디칼중합 등의 중합방법에 의해, 수직배향성기와 특정 관능기를 갖는 중합체를 생성한다. 이어서, 이 특정 관능기와 반응하는 기 및 C=C이중결합을 포함하는 중합성기를 갖는 화합물(이하, 특정 화합물이라 칭한다.)을 반응시킴으로써, (A)성분의 폴리머를 얻을 수 있다.The method of obtaining the polymer of (A) component of this invention is not specifically limited. For example, a polymer having a vertical alignment group and a specific functional group is produced by a polymerization method such as radical polymerization in advance. Subsequently, the polymer of (A) component can be obtained by making the compound which reacts with this specific functional group, and the compound (henceforth a specific compound) having a polymeric group containing a C = C double bond react.
그 밖의 방법으로는, 특정 관능기를 갖는 중합체에 대해, 특정 관능기와 반응하는 기 및 수직배향성기를 갖는 화합물, 특정 관능기와 반응하는 기 및 C=C이중결합을 포함하는 중합성기를 갖는 화합물을 반응시킴으로써, (A)성분의 폴리머를 얻을 수 있다.As another method, a polymer having a specific functional group is reacted with a compound having a group and a vertical alignment group reacting with a specific functional group, a compound having a group reacting with a specific functional group and a polymerizable group including a C = C double bond. And the polymer of (A) component can be obtained.
여기서, 특정 관능기란, 카르복실기, 에폭시기, 하이드록시기, 활성수소를 갖는 아미노기, 페놀성 하이드록시기 혹은 이소시아네이트기 등의 관능기, 또는, 이들로부터 선택되는 복수종의 관능기를 말한다.Here, a specific functional group means functional groups, such as a carboxyl group, an epoxy group, a hydroxyl group, the amino group which has an active hydrogen, a phenolic hydroxyl group, or an isocyanate group, or multiple types of functional group selected from these.
상기 서술한 특정 관능기와의 반응에 있어서, 특정 관능기와, 특정 화합물이 갖는 관능기로서 반응에 관여하는 기와의 바람직한 조합은, 카르복실기와 에폭시기, 하이드록시기와 이소시아네이트기, 페놀성 하이드록시기와 에폭시기, 카르복실기와 이소시아네이트기, 아미노기와 이소시아네이트기, 또는, 하이드록시기와 산클로라이드 등이다.In reaction with the specific functional group mentioned above, the preferable combination of a specific functional group and group which participates in reaction as a functional group which a specific compound has is a carboxyl group, an epoxy group, a hydroxyl group, and an isocyanate group, a phenolic hydroxyl group, an epoxy group, and a carboxyl group Isocyanate group, an amino group, and an isocyanate group, or a hydroxyl group and an acid chloride.
또한, 특정 관능기를 갖는 중합체를 얻는 방법은, 특별히 한정되지 않는다. 일 예로는, 특정 화합물과 반응하기 위한 관능기(특정 관능기)를 갖는 모노머, 즉, 카르복실기, 에폭시기, 하이드록시기, 활성수소를 갖는 아미노기, 페놀성 하이드록시기 또는 이소시아네이트기 등을 갖는 모노머(특정 모노머라고도 한다)를 중합하여 얻을 수 있다. 여기서, 중합에 이용하는 특정 관능기를 갖는 모노머는, 단독일 수도 있고, 중합 중에 반응하지 않는 조합이면 복수종을 병용할 수도 있다.In addition, the method of obtaining the polymer which has a specific functional group is not specifically limited. For example, a monomer having a functional group (specific functional group) for reacting with a specific compound, that is, a monomer having a carboxyl group, an epoxy group, a hydroxyl group, an amino group having active hydrogen, a phenolic hydroxyl group or an isocyanate group (specific monomer) It can be obtained by polymerization). Here, the monomer which has a specific functional group used for superposition | polymerization may be individual, and may use multiple types together if it is a combination which does not react during superposition | polymerization.
이하에, 상기의 특정 관능기를 갖는 중합체를 얻는데 필요한 모노머, 즉, 특정 모노머의 구체예를 든다. 단, 이것들로 한정되는 것은 아니다.Below, the specific example of the monomer required to obtain the polymer which has said specific functional group, ie, a specific monomer, is given. However, it is not limited to these.
카르복실기를 갖는 모노머로는, 예를 들어, 아크릴산, 메타크릴산, 크로톤산, 모노-(2-(아크릴로일옥시)에틸)프탈레이트, 모노-(2-(메타크릴로일옥시)에틸)프탈레이트, N-(카르복시페닐)말레이미드, N-(카르복시페닐)메타크릴아미드 및 N-(카르복시페닐)아크릴아미드 등을 들 수 있다.Examples of the monomer having a carboxyl group include acrylic acid, methacrylic acid, crotonic acid, mono- (2- (acryloyloxy) ethyl) phthalate, and mono- (2- (methacryloyloxy) ethyl) phthalate. , N- (carboxyphenyl) maleimide, N- (carboxyphenyl) methacrylamide, N- (carboxyphenyl) acrylamide, and the like.
에폭시기를 갖는 모노머로는, 예를 들어, 글리시딜메타크릴레이트, 글리시딜아크릴레이트, 3,4-에폭시시클로헥실메틸메타크릴레이트, 알릴글리시딜에테르, 3-에테닐-7-옥사비시클로[4.1.0]헵탄, 1,2-에폭시-5-헥센 및 1,7-옥타디엔모노에폭사이드 등을 들 수 있다.As a monomer which has an epoxy group, glycidyl methacrylate, glycidyl acrylate, 3, 4- epoxycyclohexyl methyl methacrylate, allyl glycidyl ether, 3-ethenyl-7-oxa, for example Bicyclo [4.1.0] heptane, 1,2-epoxy-5-hexene, 1,7-octadiene monoepoxide and the like.
하이드록시기를 갖는 모노머로는, 예를 들어, 2-하이드록시에틸아크릴레이트, 2-하이드록시에틸메타크릴레이트, 2-하이드록시프로필아크릴레이트, 2-하이드록시프로필메타크릴레이트, 4-하이드록시부틸아크릴레이트, 4-하이드록시부틸메타크릴레이트, 2,3-디하이드록시프로필아크릴레이트, 2,3-디하이드록시프로필메타크릴레이트, 디에틸렌글리콜모노아크릴레이트, 디에틸렌글리콜모노메타크릴레이트, 카프로락톤2-(아크릴로일옥시)에틸에스테르, 카프로락톤2-(메타크릴로일옥시)에틸에스테르, 폴리(에틸렌글리콜)에틸에테르아크릴레이트, 폴리(에틸렌글리콜)에틸에테르메타크릴레이트, 5-아크릴로일옥시-6-하이드록시노보넨-2-카르복실릭-6-락톤 및 5-메타크릴로일옥시-6-하이드록시노보넨-2-카르복실릭-6-락톤 등을 들 수 있다.As a monomer which has a hydroxy group, 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, 2-hydroxypropyl methacrylate, 4-hydroxy, for example. Butyl acrylate, 4-hydroxybutyl methacrylate, 2,3-dihydroxypropyl acrylate, 2,3-dihydroxypropyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate , Caprolactone 2- (acryloyloxy) ethyl ester, caprolactone 2- (methacryloyloxy) ethyl ester, poly (ethylene glycol) ethyl ether acrylate, poly (ethylene glycol) ethyl ether methacrylate, 5 Acryloyloxy-6-hydroxynorbornene-2-carboxylic-6-lactone and 5-methacryloyloxy-6-hydroxynorbornene-2-carboxylic-6-lactone Can be.
아미노기를 갖는 모노머로는, 예를 들어, 2-아미노에틸아크릴레이트 및 2-아미노메틸메타크릴레이트 등을 들 수 있다.As a monomer which has an amino group, 2-aminoethyl acrylate, 2-aminomethyl methacrylate, etc. are mentioned, for example.
페놀성 하이드록시기를 갖는 모노머로는, 예를 들어, 하이드록시스티렌, N-(하이드록시페닐)아크릴아미드, N-(하이드록시페닐)메타크릴아미드 및 N-(하이드록시페닐)말레이미드 등을 들 수 있다.Examples of the monomer having a phenolic hydroxy group include hydroxystyrene, N- (hydroxyphenyl) acrylamide, N- (hydroxyphenyl) methacrylamide, N- (hydroxyphenyl) maleimide, and the like. Can be mentioned.
이소시아네이트기를 갖는 모노머로는, 예를 들어, 아크릴로일에틸이소시아네이트, 메타크릴로일에틸이소시아네이트 및 m-테트라메틸자일렌이소시아네이트 등을 들 수 있다.As a monomer which has an isocyanate group, acryloyl ethyl isocyanate, methacryloyl ethyl isocyanate, m-tetramethyl xylene isocyanate, etc. are mentioned, for example.
또한, 본 발명에 있어서는, 특정 관능기를 갖는 중합체를 얻을 때에, 특정 모노머 외에, 이 모노머와 공중합가능하면서 특정 관능기를 갖지 않는 모노머를 병용할 수 있다.In addition, in this invention, when obtaining the polymer which has a specific functional group, the monomer which can copolymerize with this monomer and does not have a specific functional group can be used together besides a specific monomer.
이러한 모노머의 구체예로는, 특정 모노머와는 상이한 구조를 갖는 아크릴산에스테르 화합물 또는 메타크릴산에스테르 화합물, 말레이미드 화합물, 아크릴아미드 화합물, 아크릴로니트릴, 말레산무수물, 스티렌 화합물 및 비닐 화합물 등을 들 수 있다.As an example of such a monomer, the acrylic acid ester compound or the methacrylic acid ester compound which have a structure different from a specific monomer, a maleimide compound, an acrylamide compound, an acrylonitrile, a maleic anhydride, a styrene compound, a vinyl compound, etc. are mentioned. Can be.
이하, 상기 모노머의 구체예를 드나, 이것들로 한정되는 것은 아니다.Hereinafter, although the specific example of the said monomer is given, it is not limited to these.
상기 특정 모노머와는 상이한 구조를 갖는 아크릴산에스테르 화합물로는, 예를 들어, 메틸아크릴레이트, 에틸아크릴레이트, n-프로필아크릴레이트, 이소프로필아크릴레이트, n-부틸아크릴레이트, 이소부틸아크릴레이트, t-부틸아크릴레이트, 벤질아크릴레이트, 나프틸아크릴레이트, 안트릴아크릴레이트, 안트릴메틸아크릴레이트, 페닐아크릴레이트, 2,2,2-트리플루오로에틸아크릴레이트, 시클로헥실아크릴레이트, 이소보닐아크릴레이트, 2-메톡시에틸아크릴레이트, 메톡시트리에틸렌글리콜아크릴레이트, 2-에톡시에틸아크릴레이트, 테트라하이드로푸르푸릴아크릴레이트, 3-메톡시부틸아크릴레이트, 2-메틸-2-아다만틸아크릴레이트, 2-프로필-2-아다만틸아크릴레이트, 8-메틸-8-트리시클로데실아크릴레이트, 및, 8-에틸-8-트리시클로데실아크릴레이트 등을 들 수 있다.As an acrylic acid ester compound which has a structure different from the said specific monomer, For example, methyl acrylate, ethyl acrylate, n-propyl acrylate, isopropyl acrylate, n-butyl acrylate, isobutyl acrylate, t -Butyl acrylate, benzyl acrylate, naphthyl acrylate, anthryl acrylate, anthryl methyl acrylate, phenyl acrylate, 2,2,2-trifluoroethyl acrylate, cyclohexyl acrylate, isobornyl acrylate Rate, 2-methoxyethyl acrylate, methoxytriethylene glycol acrylate, 2-ethoxyethyl acrylate, tetrahydrofurfuryl acrylate, 3-methoxy butyl acrylate, 2-methyl-2-adamantyl Acrylate, 2-propyl-2-adamantyl acrylate, 8-methyl-8-tricyclodecyl acrylate, and 8-ethyl-8-tricyclodecyl acrylate The can.
상기 특정 모노머와는 상이한 구조를 갖는 메타크릴산에스테르 화합물로는, 예를 들어, 메틸메타크릴레이트, 에틸메타크릴레이트, n-프로필메타크릴레이트, 이소프로필메타크릴레이트, n-부틸메타크릴레이트, 이소부틸메타크릴레이트, t-부틸메타크릴레이트, 벤질메타크릴레이트, 나프틸메타크릴레이트, 안트릴메타크릴레이트, 안트릴메틸메타크릴레이트, 페닐메타크릴레이트, 2,2,2-트리플루오로에틸메타크릴레이트, 시클로헥실메타크릴레이트, 이소보닐메타크릴레이트, 2-메톡시에틸메타크릴레이트, 메톡시트리에틸렌글리콜메타크릴레이트, 2-에톡시에틸메타크릴레이트, 테트라하이드로푸르푸릴메타크릴레이트, 3-메톡시부틸메타크릴레이트, 2-메틸-2-아다만틸메타크릴레이트, γ-부티로락톤메타크릴레이트, 2-프로필-2-아다만틸메타크릴레이트, 8-메틸-8-트리시클로데실메타크릴레이트, 및, 8-에틸-8-트리시클로데실메타크릴레이트 등을 들 수 있다.As methacrylic acid ester compound which has a structure different from the said specific monomer, For example, methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate, n-butyl methacrylate , Isobutyl methacrylate, t-butyl methacrylate, benzyl methacrylate, naphthyl methacrylate, anthryl methacrylate, anthryl methyl methacrylate, phenyl methacrylate, 2,2,2-tri Fluoroethyl methacrylate, cyclohexyl methacrylate, isobornyl methacrylate, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofurfuryl Methacrylate, 3-methoxybutyl methacrylate, 2-methyl-2-adamantyl methacrylate, γ-butyrolactone methacrylate, 2-propyl-2-adamantyl methacrylate, 8- Methyl-8- tricyclodecyl methacrylate, 8-ethyl-8- tricyclodecyl methacrylate, etc. are mentioned.
상기 비닐 화합물로는, 예를 들어, 메틸비닐에테르, 벤질비닐에테르, 비닐나프탈렌, 비닐카바졸, 알릴글리시딜에테르, 3-에테닐-7-옥사비시클로[4.1.0]헵탄, 1,2-에폭시-5-헥센, 및, 1,7-옥타디엔모노에폭사이드 등을 들 수 있다.As said vinyl compound, methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl carbazole, allyl glycidyl ether, 3-ethenyl-7-oxabicyclo [4.1.0] heptane, 1, 2-epoxy-5-hexene, and 1,7-octadiene monoepoxide etc. are mentioned.
상기 스티렌 화합물로는, 예를 들어, 스티렌, 메틸스티렌, 클로로스티렌, 브로모스티렌 등을 들 수 있다.As said styrene compound, styrene, methyl styrene, chloro styrene, bromostyrene, etc. are mentioned, for example.
상기 말레이미드 화합물로는, 예를 들어, 말레이미드, N-메틸말레이미드, N-페닐말레이미드, 및 N-시클로헥실말레이미드 등을 들 수 있다.As said maleimide compound, maleimide, N-methyl maleimide, N-phenyl maleimide, N-cyclohexyl maleimide, etc. are mentioned, for example.
또한, 상기 특정 관능기를 갖는 중합체는 시판품을 호적하게 사용가능하다.Moreover, the polymer which has the said specific functional group can use a commercial item suitably.
에폭시기를 측쇄 또는 말단에 1개 이상 갖는 폴리머의 시판품의 구체예로는, 비스페놀A형 에폭시 수지로는, jER1001, 동(同) 1002, 동 1003, 동 1004, 동 1055, 동 1007, 동 1009, 동 1010, 동 834, 동 828(이상, 미쯔비시화학(주)제) 등을, 비스페놀F형 에폭시 수지로는, jER806, 동 807(이상, 미쯔비시화학(주)제) 등을, 페놀노볼락형 에폭시 수지로는, jER152, 동 154(이상, 미쯔비시화학(주)제), EPPN201, 동 202(이상, 일본화약(주)제) 등을, 크레졸노볼락형 에폭시 수지로는, ECN-1299(아사히화성(주)제), EOCN-102, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025, EOCN-1027(이상, 일본화약(주)제), jER80S75(미쯔비시화학(주)제) 등을, 비스페놀A노볼락형 에폭시 수지로는, jER157S70(미쯔비시화학(주)제) 등을, 폴리올의 1,2-에폭시-4-(2-옥시라닐)시클로헥산 부가물로는 EHPE-3150((주)다이셀제) 등을 들 수 있다.As a specific example of the commercial item of the polymer which has one or more epoxy groups in a side chain or a terminal, As a bisphenol-A epoxy resin, jER1001, copper 1002, copper 1003, copper 1004, copper 1055, copper 1007, copper 1009, 1010, 834, 828 (above, made by Mitsubishi Chemical Co., Ltd.), etc. As a bisphenol F-type epoxy resin, jER806, 807 (above, made by Mitsubishi Chemical Co., Ltd.), etc., are phenol novolak type. Examples of the epoxy resin include jER152, copper 154 (above, manufactured by Mitsubishi Chemical Co., Ltd.), EPPN201, copper 202 (manufactured by Nippon Kayaku Co., Ltd.), and the like. Asahi Kasei Co., Ltd., EOCN-102, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025, EOCN-1027 (above, Nippon Kayaku Co., Ltd.), jER80S75 (Mitsubishi Chemical Co., Ltd. product) ) As a bisphenol A novolak-type epoxy resin, jER157S70 (made by Mitsubishi Chemical Corporation) etc. is mentioned as EHPE- as a 1, 2- epoxy- 4- (2- oxiranyl) cyclohexane addition product of a polyol. 3150 (made by Daicel Corporation) etc. are mentioned.
하이드록시기를 측쇄 또는 말단에 1개 이상 갖는 폴리머의 시판품의 구체예로는, 폴리에테르폴리올의 구체예로는 ADEKA제 아데카폴리에테르 P시리즈, G시리즈, EDP시리즈, BPX시리즈, FC시리즈, CM시리즈, 니찌유제 유니옥스(등록상표) HC-40, HC-60, ST-30E, ST-40E, G-450, G-750, 유니올(등록상표) TG-330, TG-1000, TG-3000, TG-4000, HS-1600D, DA-400, DA-700, DB-400, 노니온(등록상표) LT-221, ST-221, OT-221 등을, 폴리에스테르폴리올의 구체예로는 DIC제 폴리라이트(등록상표) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, OD-X-668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD-X-2523, OD-X-2555, OD-X-2560, 쿠라레이제 폴리올 P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, F-510, F-1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, C-590, C-1050, C-2050, C-2090, C-3090 등을, 폴리카프로락톤폴리올의 구체예로는 DIC제 폴리라이트(등록상표) OD-X-2155, OD-X-640, OD-X-2568, 다이셀화학제의 플라셀(등록상표) 205, L205AL, 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320 등을 들 수 있다.As a specific example of the commercial item of the polymer which has one or more hydroxyl groups in a side chain or a terminal, As a specific example of a polyether polyol, Adeka polyether P series, G series, EDP series, BPX series, FC series, CM by ADEKA Series, Nichi Oil Uniox (registered trademark) HC-40, HC-60, ST-30E, ST-40E, G-450, G-750, Uniol (registered trademark) TG-330, TG-1000, TG- 3000, TG-4000, HS-1600D, DA-400, DA-700, DB-400, Nonion® LT-221, ST-221, OT-221 and the like as specific examples of the polyester polyol Polylite (registered trademark) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, OD-X-668, OD-X-2108, made by DIC OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD-X-2523, OD-X-2555, OD- X-2560, Kuraray polyol P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, F-510, F-1010, F-2010, F- 3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, C-590, C-1050, C-2050, C-2090, C-3090, etc. Spheres of Lactone Polyols Furnace 205, L205AL, 205U, 208, 210, 212 L212AL, 220, 230, 240, 303, 305, 308, 312, 320, etc. are mentioned.
(A)성분의 폴리머는, 중량평균분자량이 1,000 내지 200,000인 것이 바람직하고, 2,000 내지 150,000인 것이 보다 바람직하고, 3,000 내지 100,000인 것이 더욱 바람직하다. 중량평균분자량이 200,000을 초과하여 과대한 것이면, 용제에 대한 용해성이 저하되어 핸들링성이 저하되는 경우가 있고, 중량평균분자량이 1,000 미만으로 과소한 것이면, 광경화시에 경화부족이 되어 용제내성 및 내열성이 저하되는 경우가 있다.It is preferable that the weight average molecular weights of the polymer of (A) component are 1,000-200,000, It is more preferable that it is 2,000-150,000, It is further more preferable that it is 3,000-100,000. If the weight average molecular weight is over 200,000, the solubility in the solvent may be lowered and the handling property may be lowered. If the weight average molecular weight is less than 1,000, the curing resistance may be insufficient at the time of photocuring, resulting in solvent resistance and Heat resistance may fall.
한편, 본 명세서에 있어서, 중량평균분자량은 겔퍼미에이션 크로마토그래피(GPC)에 의해, 표준시료로서 폴리스티렌을 이용하여 얻어지는 값이다.In addition, in this specification, a weight average molecular weight is a value obtained by using gel permeation chromatography (GPC) using polystyrene as a standard sample.
(A)성분의 폴리머 중, 수직배향성기의 존재비율이, 이 폴리머의 전체반복단위 100몰당, 3몰%~50몰%인 것이 바람직하고, 5몰%~45몰%인 것이 더욱 바람직하다. 3몰% 미만인 경우는 수직배향성이 불충분해지는 경우가 있고, 50몰%보다 과대한 경우는, 액정과의 밀착성에 악영향을 미칠 경우가 있다.It is preferable that it is 3 mol%-50 mol% per 100 mol of all repeating units of this polymer, and, as for the polymer of (A) component, it is more preferable that they are 5 mol%-45 mol%. When it is less than 3 mol%, vertical orientation may become inadequate, and when it exceeds 50 mol%, it may adversely affect adhesiveness with a liquid crystal.
(A)성분의 폴리머 중, C=C이중결합을 포함하는 중합성기의 존재비율이, 이 폴리머의 전체반복단위 100몰당, 20몰%~97몰%인 것이 바람직하고, 25몰%~95몰%인 것이 더욱 바람직하다. 20몰% 미만인 경우는, 경화가 불충분해지는 경우가 있고, 97몰%보다 과대한 경우는, 수직배향성이 불충분해지는 경우가 있다.It is preferable that it is 20 mol%-97 mol% per 100 mol of total repeating units of this polymer in the polymer of (A) component, and the abundance rate of the polymeric group containing C = C double bond is 25 mol%-95 mol It is more preferable that it is%. When it is less than 20 mol%, hardening may become inadequate, and when it is excessive than 97 mol%, vertical orientation may become inadequate.
<(B)성분><(B) component>
본 발명의 경화막 형성 조성물에 있어서의 (B)성분은, 라디칼중합개시제이다.(B) component in the cured film formation composition of this invention is a radical polymerization initiator.
라디칼중합개시제로는, 공지의 것을 사용하는 것이 가능하며, 예를 들어, 알킬페논류, 벤조페논류, 아실포스핀옥사이드류, 미힐러의 벤조일벤조에이트류, 옥심에스테르류, 테트라메틸티우람모노설파이드류, 티오크산톤류 등을 들 수 있다.As a radical polymerization initiator, a well-known thing can be used, For example, alkyl phenones, benzophenones, acyl phosphine oxides, Michler's benzoyl benzoate, oxime ester, tetramethyl thiuram mono Sulfides, thioxanthones and the like.
본 발명에서 이용되는 라디칼중합개시제로는, 예를 들어, 디아세틸 등의 α-디케톤류; 벤조인 등의 아실로인류; 벤조인메틸에테르, 벤조인에틸에테르, 벤조인이소프로필에테르 등의 아실로인에테르류; 티오크산톤, 2,4-디에틸티오크산톤, 티오크산톤-4-설폰산, 벤조페논, 4,4’-비스(디메틸아미노)벤조페논, 4,4’-비스(디에틸아미노)벤조페논 등의 벤조페논류; 아세토페논, p-디메틸아미노아세토페논, α,α-디메톡시-α-아세톡시아세토페논, α,α-디메톡시-α-페닐아세토페논, p-메톡시아세토페논, 1-[2-메틸-4-메틸티오페닐]-2-모르폴리노-1-프로판온, α,α-디메톡시-α-모르폴리노-메틸티오페닐아세토페논, 2-벤질-2-디메틸아미노-1-(4-모르폴리노페닐)-부탄-1-온 등의 아세토페논류; 안트라퀴논, 1,4-나프토퀴논 등의 퀴논류; 페나실클로라이드, 트리브로모메틸페닐설폰, 트리스(트리클로로메틸)-s-트리아진 등의 할로겐 화합물; [1,2’-비스이미다졸]-3,3’,4,4’-테트라페닐, [1,2’-비스이미다졸]-1,2’-디클로로페닐-3,3’,4,4’-테트라페닐 등의 비스이미다졸류, 디-tert-부틸퍼옥사이드 등의 과산화물; 2,4,6-트리메틸벤조일디페닐포스핀옥사이드 등의 아실포스핀옥사이드류 등을 들 수 있다.As a radical polymerization initiator used by this invention, For example, alpha-diketones, such as diacetyl; Acyl phosphorus such as benzoin; Acyloin ethers such as benzoin methyl ether, benzoin ethyl ether and benzoin isopropyl ether; Thioxanthone, 2,4-diethyl thioxanthone, thioxanthone-4-sulfonic acid, benzophenone, 4,4'-bis (dimethylamino) benzophenone, 4,4'-bis (diethylamino) Benzophenones such as benzophenone; Acetophenone, p-dimethylaminoacetophenone, α, α-dimethoxy-α-acetoxyacetophenone, α, α-dimethoxy-α-phenylacetophenone, p-methoxyacetophenone, 1- [2-methyl -4-methylthiophenyl] -2-morpholino-1-propanone, α, α-dimethoxy-α-morpholino-methylthiophenylacetophenone, 2-benzyl-2-dimethylamino-1- ( Acetophenones such as 4-morpholinophenyl) -butan-1-one; Quinones such as anthraquinone and 1,4-naphthoquinone; Halogen compounds such as phenacyl chloride, tribromomethylphenyl sulfone, and tris (trichloromethyl) -s-triazine; [1,2'-bisimidazole] -3,3 ', 4,4'-tetraphenyl, [1,2'-bisimidazole] -1,2'-dichlorophenyl-3,3', 4, Peroxides, such as bisimidazoles, such as 4'- tetraphenyl, and di-tert- butyl peroxide; And acyl phosphine oxides such as 2,4,6-trimethylbenzoyldiphenylphosphine oxide.
시판품으로는, 이가큐어 184, 369, 379EG, 651, 500, 907, CGI369, CG24-61, OXE02, 루시린 LR8728, 루시린 TPO, 다로큐어 1116, 1173(이상, BASF(주)제), 유베크릴 P36(UCB(주)제) 등의 상품명으로 시판되고 있는 것을 들 수 있다.As a commercial item, Igacure 184, 369, 379EG, 651, 500, 907, CGI369, CG24-61, OXE02, Lucirin LR8728, Lucirin TPO, Tarocure 1116, 1173 (more, product made in BASF Corporation), Yube What is marketed by brand names, such as a krill P36 (made by UCB Corporation), are mentioned.
상기 중에서도, 1-[2-메틸-4-메틸티오페닐]-2-모르폴리노-1-프로판온, 2-벤질-2-디메틸아미노-1-(4-모르폴리노페닐)-부탄-1-온, α,α-디메톡시-α-페닐아세토페논 등의 아세토페논류, 페나실클로라이드, 트리브로모메틸페닐설폰, 2,4,6-트리메틸벤조일디페닐포스핀옥사이드, 1,2’-비스이미다졸류와 4,4’-비스(디에틸아미노)벤조페논과 메르캅토벤조티아졸과의 병용, 루시린 TPO(상품명), 이가큐어 651(상품명), 이가큐어 369(상품명), 이가큐어 907(상품명), 이가큐어 OXE02(상품명)가 바람직하다.Among the above, 1- [2-methyl-4-methylthiophenyl] -2-morpholino-1-propanone and 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) -butane- Acetophenones such as 1-one, α, α-dimethoxy-α-phenylacetophenone, phenacyl chloride, tribromomethylphenylsulfone, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 1,2 ' Combination of -bisimidazole with 4,4'-bis (diethylamino) benzophenone and mercapto benzothiazole, Lucirin TPO (brand name), Igacure 651 (brand name), Igacure 369 (brand name), Igacure 907 (brand name) and Igacure OXE02 (brand name) are preferable.
상기 라디칼중합개시제는, 1종 단독으로 이용할 수도 2종 이상을 조합하여 이용할 수도 있다.The radical polymerization initiators may be used alone, or may be used in combination of two or more thereof.
상기 라디칼중합개시제는, (A)성분 100질량부에 대해, 바람직하게는 0.1~50질량부, 보다 바람직하게는 1~30질량부, 특히 바람직하게는 2~30질량부의 양으로 이용할 수 있다. 라디칼중합개시제의 사용량이 상기 범위보다 적으면, 산소에 의한 라디칼의 실활의 영향(감도의 저하)을 받기 쉽고, 상기 범위보다 많으면, 상용성이 나빠지거나, 보존안정성이 저하되거나 하는 경향이 있다.The radical polymerization initiator is preferably 0.1 to 50 parts by mass, more preferably 1 to 30 parts by mass, and particularly preferably 2 to 30 parts by mass with respect to 100 parts by mass of the component (A). When the amount of the radical polymerization initiator used is less than the above range, it is easy to be affected by the deactivation of the radicals due to oxygen (decrease in sensitivity). When the radical polymerization initiator is more than the above range, the compatibility tends to be poor and the storage stability tends to decrease.
<(C)성분><(C) component>
본 발명의 경화막 형성 조성물은, (C)성분으로서, C=C이중결합을 포함하는 중합성기를 갖는 모노머 및 폴리머로 이루어지는 군으로부터 선택되는 적어도 1종을 함유하고 있을 수도 있다.The cured film formation composition of this invention may contain at least 1 sort (s) chosen from the group which consists of a monomer and a polymer which have a polymeric group containing C = C double bond as (C) component.
한편, 본 명세서에서는 (메트)아크릴레이트 화합물이란, 아크릴레이트 화합물과 메타크릴레이트 화합물의 양방을 말한다. 예를 들어 (메트)아크릴산은, 아크릴산과 메타크릴산을 말한다. 또한, (메트)아크릴로일기는, CH2=CHCO-와, CH(CH3)=CHCO-를 나타낸다.In addition, in this specification, a (meth) acrylate compound means both an acrylate compound and a methacrylate compound. For example, (meth) acrylic acid means acrylic acid and methacrylic acid. In addition, the (meth) acryloyl group represents a CH 2 = CHCO-, and, CH (CH 3) = CHCO- .
이하, 본 발명의 (C)성분 C=C이중결합을 포함하는 중합성기를 갖는 모노머 및 폴리머로는, 막강도를 높이는 관점으로부터, C=C이중결합을 포함하는 중합성기를 1분자 중에 2개 이상 갖는 모노머 및 폴리머가 바람직하다. 이하, 호적한 화합물의 일 예를 드나, (C)성분은 이들 예시로 한정되는 것은 아니다.Hereinafter, as a monomer and a polymer which have a polymeric group containing (C) component C = C double bond of this invention, from a viewpoint of raising a film strength, two polymerizable groups containing C = C double bond are contained in 1 molecule. The monomer and polymer which have the above are preferable. Hereinafter, although the example of a suitable compound is given, (C) component is not limited to these illustrations.
(메트)아크릴로일기를 2개 갖는 화합물로는, 예를 들어 에틸렌글리콜디(메트)아크릴레이트, 디에틸렌글리콜디(메트)아크릴레이트, 트리에틸렌글리콜디(메트)아크릴레이트, 프로필렌글리콜디(메트)아크릴레이트, 네오펜틸글리콜디(메트)아크릴레이트, 폴리에틸렌글리콜디(메트)아크릴레이트, 폴리프로필렌글리콜디(메트)아크릴레이트, 1,4-부탄디올디(메트)아크릴레이트, 네오펜틸글리콜디(메트)아크릴레이트, 1,6-헥산디올디(메트)아크릴레이트, 1,9-노난디올디(메트)아크릴레이트, 2-메틸-1,8-옥탄디올디(메트)아크릴레이트, 1,10-데칸디올디(메트)아크릴레이트, 펜타에리스리톨디(메트)아크릴레이트, 트리시클로[5.2.1.02,6]데칸디메탄올디(메트)아크릴레이트, 디옥산글리콜디(메트)아크릴레이트, 2-하이드록시-1-아크릴로일옥시-3-메타크릴로일옥시프로판, 2-하이드록시-1,3-디(메트)아크릴로일옥시프로판, 트리스하이드록시에틸이소시아누레이트디(메트)아크릴레이트, 9,9-비스[4-(2-(메트)아크릴로일옥시에톡시)페닐]플루오렌, 운데실렌옥시에틸렌글리콜디(메트)아크릴레이트, 1,3-아다만탄디올디(메트)아크릴레이트, 1,3-아다만탄디메탄올디(메트)아크릴레이트, 에톡시화비스페놀A디(메트)아크릴레이트 등을 들 수 있다.As a compound which has two (meth) acryloyl groups, for example, ethylene glycol di (meth) acrylate, diethylene glycol di (meth) acrylate, triethylene glycol di (meth) acrylate, and propylene glycol di ( Meth) acrylate, neopentyl glycol di (meth) acrylate, polyethylene glycol di (meth) acrylate, polypropylene glycol di (meth) acrylate, 1,4-butanediol di (meth) acrylate, neopentyl glycoldi (Meth) acrylate, 1,6-hexanedioldi (meth) acrylate, 1,9-nonanedioldi (meth) acrylate, 2-methyl-1,8-octanedioldi (meth) acrylate, 1 , 10-decanedioldi (meth) acrylate, pentaerythritoldi (meth) acrylate, tricyclo [5.2.1.0 2,6 ] decanedimethanoldi (meth) acrylate, dioxane glycoldi (meth) acrylate 2-hydroxy-1-acryloyloxy-3-methacryloyloxypropane, 2-hydroxy-1,3-di (meth) acryloyloxypropane, trishydroxyethyl isocyanurate di (meth) acrylate, 9,9-bis [4- (2- (meth) acrylo Iloxyethoxy) phenyl] fluorene, undecyleneoxyethylene glycol di (meth) acrylate, 1,3-adamantanedioldi (meth) acrylate, 1,3-adamantanedimethanoldi (meth) acrylic Ethoxylated bisphenol A di (meth) acrylate etc. are mentioned.
(메트)아크릴로일기를 2개 이상 갖는 화합물은, 시판품을 호적하게 사용할 수 있고, 예를 들어, 라이트아크릴레이트 3EG-A, 라이트아크릴레이트 4EG-A, 라이트아크릴레이트 9EG-A, 라이트아크릴레이트 14EG-A, 라이트아크릴레이트 PTMGA-250, 라이트아크릴레이트 NP-A, 라이트아크릴레이트 MPD-A, 라이트아크릴레이트 1.6HX-A, 라이트아크릴레이트 1.9ND-A, 라이트아크릴레이트 MOD-A, 라이트아크릴레이트 DCP-A, 라이트아크릴레이트 BP-4EAL, 라이트아크릴레이트 BP-4PA, 라이트아크릴레이트 HPP-A, 라이트에스테르 G-201P, 라이트에스테르 P-2M, 라이트에스테르 EG, 라이트에스테르 2EG, 라이트에스테르 3EG, 라이트에스테르 4EG, 라이트에스테르 9EG, 라이트에스테르 14EG, 라이트에스테르 1.4BG, 라이트에스테르 NP, 라이트에스테르 1.6HX, 라이트에스테르 1.9ND, 라이트에스테르 G-101P, 라이트에스테르 G-201P, 라이트에스테르 BP-2EMK[이상, 모두 쿄에이샤화학(주)제]; NK에스테르701A, 동 A-200, 동 A-400, 동 A-600, 동 A-1000, 동 A-B1206PE, 동 ABE-300, 동 A-BPE-10, 동 A-BPE-20, 동 A-BPE-30, 동 A-BPE-4, 동 A-BPEF, 동 A-BPP-3, 동 A-DCP, 동 A-DOD-N, 동 A-HD-N, 동 A-NOD-N, 동 APG-100, 동 APG-200, 동 APG-400, 동 APG-700, 동 A-PTMG-65, 동 1G, 동 2G, 동 3G, 동 4G, 동 9G, 동 14G, 동 23G, 동 BPE-80N, 동 BPE-100, 동 BPE-200, 동 BPE-500, 동 BPE-900, 동 BPE-1300N, 동 DCP, 동 DCP-N, 동 HD-N, 동 NOD-N, 동 NPG, 동 1206PE, 동 701, 동 9PG[이상, 모두 신나카무라화학공업(주)제]; FANCRYL FA-124AS, 동 FA-129AS, 동 FA-222A, 동 FA-240A, 동 FA-P240A, 동 FA-P270A, 동 FA-321A, 동 FA-324A, 동 FA-PTG9A, 동 FA-121M, 동 FA-124M, 동 FA-125M, 동 FA-220M, 동 FA-240M, 동 FA-320M, 동 FA-321M, 동 FA-3218M, 동 FA-PTG9M[이상, 모두 히타치화성(주)제]; DPGDA, HODA, TPGDA, EBECRYL(등록상표) 145, 동 150, IRR214-K, PEG400DA-D, EBECRYL(등록상표) 11, HPDNA[다이셀올넥스(주)제]; 비스코트 #195, 동 #230, 동 #260, 동 #310HP, 동 #335HP, 동 #700HV, 동 #540, 동 #802, 동 #295[이상, 모두 일본합성화학공업(주)제] 등을 들 수 있다.The compound which has two or more (meth) acryloyl groups can use a commercial item suitably, For example, light acrylate 3EG-A, light acrylate 4EG-A, light acrylate 9EG-A, light acrylate 14EG-A, Lightacrylate PTMGA-250, Lightacrylate NP-A, Lightacrylate MPD-A, Lightacrylate 1.6HX-A, Lightacrylate 1.9ND-A, Lightacrylate MOD-A, Lightacryl Light DCP-A, light acrylate BP-4EAL, light acrylate BP-4PA, light acrylate HPP-A, light ester G-201P, light ester P-2M, light ester EG, light ester 2EG, light ester 3EG, Light Ester 4EG, Light Ester 9EG, Light Ester 14EG, Light Ester 1.4BG, Light Ester NP, Light Ester 1.6HX, Light Ester 1.9ND, Light Ester G-101P, Light Hotel's G-201P, Light Ester BP-2EMK [above, both the Tokyo Ischia Chemical (Co., Ltd.); NK ester 701A, copper A-200, copper A-400, copper A-600, copper A-1000, copper A-B1206PE, copper ABE-300, copper A-BPE-10, copper A-BPE-20, copper A -BPE-30, A-BPE-4, A-BPEF, A-BPP-3, A-DCP, A-DOD-N, A-HD-N, A-NOD-N, East APG-100, East APG-200, East APG-400, East APG-700, East A-PTMG-65, East 1G, East 2G, East 3G, East 4G, East 9G, East 14G, East 23G, East BPE -80N, copper BPE-100, copper BPE-200, copper BPE-500, copper BPE-900, copper BPE-1300N, copper DCP, copper DCP-N, copper HD-N, copper NOD-N, copper NPG, copper 1206PE, copper 701, copper 9PG (above, all manufactured by Shin-Nakamura Chemical Co., Ltd.); FANCRYL FA-124AS, East FA-129AS, East FA-222A, East FA-240A, East FA-P240A, East FA-P270A, East FA-321A, East FA-324A, East FA-PTG9A, East FA-121M, East FA-124M, East FA-125M, East FA-220M, East FA-240M, East FA-320M, East FA-321M, East FA-3218M, East FA-PTG9M [above, all made by Hitachi Chemical Co., Ltd.] ; DPGDA, HODA, TPGDA, EBECRYL® 145, Iso 150, IRR214-K, PEG400DA-D, EBECRYL® 11, HPDNA [manufactured by Daicelolnex Corporation]; Biscot # 195, East # 230, East # 260, East # 310HP, East # 335HP, East # 700HV, East # 540, East # 802, East # 295 [above, all manufactured by Japan Synthetic Chemical Industries, Ltd.], etc. Can be mentioned.
(메트)아크릴로일기를 3개 갖는 화합물(3관능 화합물)로는, 예를 들어, 에틸렌옥사이드변성1,1,1-트리메틸올에탄트리(메트)아크릴레이트[에틸렌옥사이드부가몰수 3~30], 에틸렌옥사이드변성트리메틸올프로판트리(메트)아크릴레이트[에틸렌옥사이드부가몰수 3~30], 프로필렌옥사이드변성트리메틸올프로판트리(메트)아크릴레이트[프로필렌옥사이드부가몰수 3~30], 에틸렌옥사이드변성글리세린트리(메트)아크릴레이트[에틸렌옥사이드부가몰수 3~30], 프로필렌옥사이드변성글리세린트리(메트)아크릴레이트[프로필렌옥사이드부가몰수 3~30], 트리스(2-(아크릴로일옥시)에틸)이소시아누레이트, ε-카프로락톤변성트리스(2-(아크릴로일옥시)에틸)이소시아누레이트[ε-카프로락톤부가몰수 1~30], 1,1,1-트리메틸올에탄트리(메트)아크릴레이트, 트리메틸올프로판트리(메트)아크릴레이트, 디트리메틸올프로판트리(메트)아크릴레이트, 펜타에리스리톨트리(메트)아크릴레이트, 글리세린트리(메트)아크릴레이트 등을 들 수 있다.As a compound (trifunctional compound) which has three (meth) acryloyl groups, For example, ethylene oxide modified 1,1,1- trimethylol ethane tri (meth) acrylate [the number of ethylene oxide addition moles 3-30], Ethylene oxide modified trimethylol propane tri (meth) acrylate [ethylene oxide added mole number 3-30], propylene oxide modified trimethylol propane tri (meth) acrylate [propylene oxide added mole number 3-30], ethylene oxide modified glycerin tree ( Meth) acrylate [ethylene oxide addition mole number 3-30], propylene oxide modified glycerin tri (meth) acrylate [propylene oxide addition mole number 3-30], tris (2- (acryloyloxy) ethyl) isocyanurate (epsilon) -caprolactone modified tris (2- (acryloyloxy) ethyl) isocyanurate [ε-caprolactone addition mole number 1-30], 1,1,1- trimethylol ethane tri (meth) acrylate, Trimethylolpropane tree ( Agent) acrylate, ditrimethylolpropane tri (meth) acrylate, pentaerythritol tri (meth) acrylate, glycerin tri (meth) acrylate.
상기 3관능 화합물은, 시판품을 호적하게 사용할 수 있고, 예를 들어 비스코트 #360[오사카유기화학공업(주)제]; NK에스테르 A-GLY-9E, 동 A-GLY-20E, 동 AT-20E[이상, 모두 신나카무라화학공업(주)제]; TMPEOTA, OTA480, EBECRYL(등록상표) 135[이상, 모두 다이셀올넥스(주)제], 비스코트 #295, 동 #300[이상, 모두 오사카유기화학공업(주)제]; 라이트아크릴레이트 TMP-A, 동 PE-3A, 라이트에스테르 TMP[이상, 모두 쿄에이샤화학(주)제]; NK에스테르 A-9300, 동 A-9300-1CL, 동 A-TMM-3, 동 A-TMM-3L, 동 A-TMM-3LM-N, 동 A-TMPT, 동 TMPT[이상, 모두 신나카무라화학공업(주)제]; PETIA, PETRA, TMPTA, EBECRYL(등록상표) 180[이상, 모두 다이셀올넥스(주)제] 등을 들 수 있다.As the said trifunctional compound, a commercial item can be used suitably, For example, Biscoat # 360 [manufactured by Osaka Organic Chemical Industry Co., Ltd.]; NK ester A-GLY-9E, copper A-GLY-20E, and AT-20E (above, all made by Shin-Nakamura Chemical Co., Ltd.); TMPEOTA, OTA480, EBECRYL (registered trademark) 135 [above, all manufactured by Daicel Allnex Co., Ltd.], biscot # 295, east # 300 [more, all manufactured by Osaka Organic Chemical Industry Co., Ltd.]; Light acrylate TMP-A, copper PE-3A, light ester TMP (above, all manufactured by Kyoeisha Chemical Co., Ltd.); NK ester A-9300, copper A-9300-1CL, copper A-TMM-3, copper A-TMM-3L, copper A-TMM-3LM-N, copper A-TMPT, copper TMPT [above, all Shinnakamura Chemical Industrial Co., Ltd. product; PETIA, PETRA, TMPTA, EBECRYL (registered trademark) 180 (all are manufactured by Daicel Allnex Co., Ltd.), etc. are mentioned.
(메트)아크릴로일기를 4개 갖는 화합물(4관능 화합물)로는, 예를 들어, 에틸렌옥사이드변성디트리메틸올프로판테트라(메트)아크릴레이트[에틸렌옥사이드부가몰수 4~40], 에틸렌옥사이드변성펜타에리스리톨테트라(메트)아크릴레이트[에틸렌옥사이드부가몰수 4~40], 디트리메틸올프로판테트라(메트)아크릴레이트, 펜타에리스리톨테트라(메트)아크릴레이트 등을 들 수 있다.As a compound (4-functional compound) which has four (meth) acryloyl groups, For example, ethylene oxide modified ditrimethylol propane tetra (meth) acrylate [the number of ethylene oxide addition moles 4-40], ethylene oxide modified pentaerythritol Tetra (meth) acrylate [the number of ethylene oxide added moles 4-40], ditrimethylol propane tetra (meth) acrylate, pentaerythritol tetra (meth) acrylate, etc. are mentioned.
상기 4관능 화합물은, 시판품을 호적하게 사용할 수 있고, 예를 들어 NK에스테르 ATM-4E, 동 ATM-35E[이상, 모두 신나카무라화학공업(주)제]; EBECRYL(등록상표) 40[다이셀올넥스(주)제] 등, 비스코트 #300[오사카유기화학공업(주)제]; 라이트아크릴레이트 PE-4A[쿄에이샤화학(주)제]; NK에스테르 AD-TMP, 동 A-TMMT[이상, 모두 신나카무라화학공업(주)제]; EBECRYL(등록상표) 140, 동 1142, 동 180[이상, 모두 다이셀올넥스(주)제] 등을 들 수 있다.As said tetrafunctional compound, a commercial item can be used suitably, For example, NK ester ATM-4E and the same ATM-35E (all are the Shin-Nakamura Chemical Co., Ltd. product); Biscot # 300 [manufactured by Osaka Organic Chemical Industry Co., Ltd.] such as EBECRYL (registered trademark) 40 [manufactured by Daicel Allnex Co., Ltd.]; Light acrylate PE-4A [manufactured by Kyoeisha Chemical Co., Ltd.]; NK ester AD-TMP and copper A-TMMT (above, all made by Shin-Nakamura Chemical Co., Ltd.); EBECRYL (trademark) 140, 1142, 180 (above, all are manufactured by Daicel All-Nex Corporation), etc. are mentioned.
(메트)아크릴로일기를 5개 이상 갖는 화합물(5관능 이상의 화합물)로는, 예를 들어, 에틸렌옥사이드변성디펜타에리스리톨헥사(메트)아크릴레이트[에틸렌옥사이드부가몰수 6~60], 에틸렌옥사이드변성트리펜타에리스리톨옥타(메트)아크릴레이트[에틸렌옥사이드부가몰수 6~60], 디펜타에리스리톨펜타(메트)아크릴레이트, 디펜타에리스리톨헥사(메트)아크릴레이트, 트리펜타에리스리톨옥타(메트)아크릴레이트 등을 들 수 있다.As a compound (5-functional or more functional compound) which has five or more (meth) acryloyl groups, For example, ethylene oxide modified dipentaerythritol hexa (meth) acrylate [the number of ethylene oxide addition moles 6-60], ethylene oxide modified tree Pentaerythritol octa (meth) acrylate [ethylene oxide addition mole number 6-60], dipentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, tripentaerythritol octa (meth) acrylate, etc. are mentioned. Can be.
상기 5관능 이상의 화합물은, 시판품을 호적하게 사용할 수 있고, 예를 들어 NK에스테르 A-DPH-12E[신나카무라화학공업(주)제], 비스코트 #802[오사카유기화학공업(주)제]; 라이트아크릴레이트 DPE-6A[쿄에이샤화학(주)제]; NK에스테르 A-9550, 동 A-DPH[이상, 모두 신나카무라화학공업(주)제]; DPHA[다이셀올넥스(주)제] 등을 들 수 있다.A commercially available product can be used suitably for the said 5-functional or more compound, For example, NK ester A-DPH-12E [made by Shin-Nakamura Chemical Co., Ltd.], bis coat # 802 [manufactured by Osaka Organic Chemical Co., Ltd.] ; Light acrylate DPE-6A [manufactured by Kyoeisha Chemical Co., Ltd.]; NK ester A-9550, copper A-DPH (above, all made by Shin-Nakamura Chemical Co., Ltd.); DPHA (made by Daicel Allnex Co., Ltd.) etc. are mentioned.
2관능우레탄(메트)아크릴레이트로는, 예를 들어, 페닐글리시딜에테르의 (메트)아크릴산 부가물과 헥사메틸렌디이소시아네이트와의 우레탄화물, 페닐글리시딜에테르의 (메트)아크릴산 부가물과 톨루엔디이소시아네이트와의 우레탄화물 등을 들 수 있다.As a bifunctional urethane (meth) acrylate, the urethane compound of the (meth) acrylic acid addition product of phenylglycidyl ether, and hexamethylene diisocyanate, the (meth) acrylic acid addition product of phenylglycidyl ether, And urethane compounds with toluene diisocyanate.
상기 2관능우레탄(메트)아크릴레이트는, 시판품을 호적하게 사용할 수 있고, 예를 들어 AH-600, AT-600[이상, 모두 쿄에이샤화학(주)제]; NK올리고 U-2PPA, 동 U-200PA, 동 UA-160TM, 동 UA-290TM, 동 UA-4200, 동 UA-4400, 동 UA-122P, 동 UA-W2A[이상, 모두 신나카무라화학공업(주)제]; EBECRYL(등록상표) 210, 동 215, 동 230, 동 244, 동 245, 동 270, 동 280/15IB, 동 284, 동 285, 동 4858, 동 8307, 동 8402, 동 8411, 동 8804, 동 8807, 동 9227EA, 동 9270, KRM(등록상표) 7735[이상, 모두 다이셀올넥스(주)제]; 시코우(등록상표) UV-6630B, 동 7000B, 동 7461TE, 동 2000B, 동 2750B, 동 3000, 동 3200B, 동 3210EA, 동 3300B, 동 3310B, 동 3500BA, 동 3520TL, 동 3700B, 동 6640B[이상, 모두 일본합성화학공업(주)제] 등을 들 수 있다.As said bifunctional urethane (meth) acrylate, a commercial item can be used suitably, For example, AH-600 and AT-600 (all are the Kyoeisha Chemical Co., Ltd. product or more); NK Oligo U-2PPA, East U-200PA, East UA-160TM, East UA-290TM, East UA-4200, East UA-4400, East UA-122P, East UA-W2A [above, all Shinnakamura Chemical Co., Ltd. )My]; EBECRYL (trademark) 210, 215, 230, 244, 244, 245, 270, 280 / 15IB, 284, 285, 4858, 8830, 8402, 8402, 8411, 8804, 88807 , 9227EA, 9270, KRM (registered trademark) 7735 (above, all manufactured by Daicel Allnex Co., Ltd.); Shiko (trademark) UV-6630B, copper 7000B, copper 7461TE, copper 2000B, copper 2750B, copper 3000, copper 3200B, copper 3210EA, copper 3300B, copper 3310B, copper 3500BA, copper 3520TL, copper 3700B, copper 6640B And Japan Synthetic Chemical Co., Ltd.].
(메트)아크릴로일기를 3개 갖는 다관능우레탄(메트)아크릴레이트 화합물의 시판품의 구체예로는, NK올리고 UA-7100[신나카무라화학공업(주)제]; EBECRYL(등록상표) 204, 동 205, 동 264, 동 265, 동 294/25HD, 동 1259, 동 4820, 동 8311, 동 8465, 동 8701, 동 9260, KRM(등록상표) 8296, 동 8667[이상, 모두 다이셀올넥스(주)제]; 시코우(등록상표) UV-7550B, 동 7000B, 동 7510B, 동 7461TE, 동 2750B[이상, 모두 일본합성화학공업(주)제] 등을 들 수 있다.As a specific example of the commercial item of the polyfunctional urethane (meth) acrylate compound which has three (meth) acryloyl groups, NK oligo UA-7100 [made by Shin-Nakamura Chemical Co., Ltd.]; EBECRYL (trademark) 204, east 205, east 264, east 265, east 294 / 25HD, east 1259, east 4820, east 8311, east 8465, east 8701, east 9260, KRM (registered trademark) 8296, east 8667 , All are manufactured by Daicel Allnex Co., Ltd .; Shiko (trademark) UV-7550B, 7000B, 7510B, 7461TE, 2750B (all are manufactured by Nippon Synthetic Chemical Co., Ltd.) and the like.
(메트)아크릴로일기를 4개 갖는 다관능우레탄(메트)아크릴레이트 화합물의 시판품의 구체예로는, EBECRYL(등록상표) 8210, 동 8405, KRM(등록상표) 8528[이상, 모두 다이셀올넥스(주)제]; 시코우(등록상표) UV-7650B[일본합성화학공업(주)제] 등을 들 수 있다.As a specific example of the commercial item of the polyfunctional urethane (meth) acrylate compound which has four (meth) acryloyl groups, EBECRYL (trademark) 8210, 8405, KRM (registered trademark) 8528 [above, all are Disselolnex (subject]; Shiko (trademark) UV-7650B (made by Japan Synthetic Chemical Co., Ltd.), etc. are mentioned.
(메트)아크릴로일기를 5개 이상 갖는 다관능우레탄(메트)아크릴레이트 화합물(5관능 이상의 우레탄(메트)아크릴레이트)로는, 예를 들어, 펜타에리스리톨트리(메트)아크릴레이트와 헥사메틸렌디이소시아네이트와의 우레탄화물, 펜타에리스리톨트리(메트)아크릴레이트와 톨루엔디이소시아네이트와의 우레탄화물, 펜타에리스리톨트리(메트)아크릴레이트와 이소포론디이소시아네이트와의 우레탄화물, 디펜타에리스리톨펜타(메트)아크릴레이트와 헥사메틸렌디이소시아네이트와의 우레탄화물 등을 들 수 있다.As a polyfunctional urethane (meth) acrylate compound (five functional or more urethane (meth) acrylate) which has five or more (meth) acryloyl groups, for example, pentaerythritol tri (meth) acrylate and hexamethylene diisocyanate Urethanes with pentaerythritol tri (meth) acrylate and toluene diisocyanate, urethanes with pentaerythritol tri (meth) acrylate and isophorone diisocyanate, dipentaerythritol penta (meth) acrylate And urethane compounds with hexamethylene diisocyanate.
상기 5관능 이상의 우레탄(메트)아크릴레이트는, 시판품을 호적하게 사용할 수 있고, 예를 들어 UA-306H, UA-306T, UA-306I, UA-510H[이상, 모두 쿄에이샤화학(주)제]; NK올리고 U-6LPA, 동 U-10HA, 동 U-10PA, 동 U-1100H, 동 U-15HA, 동 UA-53H, 동 UA-33H[이상, 모두 신나카무라화학공업(주)제]; EBECRYL(등록상표) 220, 동 1290, 동 5129, 동 8254, 동 8301R, KRM(등록상표) 8200, 동 8200AE, 동 8904, 동 8452[이상, 모두 다이셀올넥스(주)제]; 시코우(등록상표) UV-1700B, 동 6300B, 동 7600B, 동 7605B, 동 7610B, 동 7620EA, 동 7630B, 동 7640B, 동 7650B[이상, 모두 일본합성화학공업(주)제] 등을 들 수 있다.Commercially available products can be suitably used for the above-mentioned 5-functional urethane (meth) acrylate, for example, UA-306H, UA-306T, UA-306I, and UA-510H [all of which are manufactured by Kyoeisha Chemical Co., Ltd.]. ]; NK oligo U-6LPA, copper U-10HA, copper U-10PA, copper U-1100H, copper U-15HA, copper UA-53H, copper UA-33H (above, all manufactured by Shin-Nakamura Chemical Co., Ltd.); EBECRYL (registered trademark) 220, 1290, 5129, 8254, 8301R, KRM (registered trademark) 8200, 8200AE, 8904, 8452 (above, all manufactured by Daicel Allnex Co., Ltd.); Shiko (trademark) UV-1700B, 6300B, 7600B, 7605B, 7610B, 7620EA, 7630B, 7640B, 7650B (above, all manufactured by Japan Synthetic Chemical Co., Ltd.), and the like. have.
본 발명의 (C)성분은, 분자 내에 말단이 중합성 불포화결합인 측쇄를 1개 이상 갖는 고분자 화합물일 수도 있다. 이러한 말단이 중합성 불포화결합인 측쇄를 갖는 고분자 화합물로는, 바람직하게는 분자 내의 2개 이상의 측쇄에 (메트)아크릴로일기를 갖는 고분자 화합물을 들 수 있다.The (C) component of this invention may be a high molecular compound which has one or more side chains whose terminal is a polymerizable unsaturated bond in a molecule | numerator. As a high molecular compound which has a side chain whose terminal is a polymerizable unsaturated bond, Preferably, the high molecular compound which has a (meth) acryloyl group in two or more side chains in a molecule | numerator is mentioned.
상기 고분자 화합물로는, 우레탄아크릴계, 에폭시아크릴계, 각종 (메트)아크릴레이트계 등의 (메트)아크릴로일기를 1개 이상 함유하는 고분자 화합물을 들 수 있다.As said high molecular compound, the high molecular compound containing one or more (meth) acryloyl groups, such as a urethane acryl type, an epoxy acryl type, and various (meth) acrylate type, is mentioned.
(C)성분의 고분자 화합물의 중량평균분자량은, 바람직하게는 1,000~200,000이고, 보다 바람직하게는 5,000~50,000이다. 분자량이 1,000 미만이면, 본 발명의 효과를 나타내지 않는 경우가 있다. 한편, 분자량이 100,000을 초과하여 과대하면, 조성물에 용해되지 않는 경우가 있다.The weight average molecular weight of the high molecular compound of (C) component becomes like this. Preferably it is 1,000-200,000, More preferably, it is 5,000-50,000. When molecular weight is less than 1,000, the effect of this invention may not be exhibited. On the other hand, when molecular weight exceeds 100,000, it may not melt | dissolve in a composition.
이러한 (C)성분인 화합물로는, 예를 들어, 아크리트 8BR-930M, 동 8UH-1006, 동 8KQ-2001, 동 8KX-078, 동 1SX-1055[이상, 다이세이파인케미칼주식회사제], SMP-250A, SMP-360A, SMP-550A[이상, 쿄에이샤화학주식회사제] 등의 폴리머를 들 수 있다.As a compound which is such (C) component, For example, Acrite 8BR-930M, 8UH-1006, 8KQ-2001, 8KX-078, 1SX-1055 [more than Daisei Fine Chemical Co., Ltd. product], And polymers such as SMP-250A, SMP-360A, and SMP-550A (above, manufactured by Kyoeisha Chemical Co., Ltd.).
(C)성분을 함유시키는 경우의 함유량은, (A)성분의 100질량부에 기초하여, 10질량부 내지 1000질량부이고, 바람직하게는, 15질량부 내지 500질량부이다.Content in the case of containing (C) component is 10 mass parts-1000 mass parts based on 100 mass parts of (A) component, Preferably they are 15 mass parts-500 mass parts.
<용제><Solvent>
본 발명의 경화막 형성 조성물은, 주로 용제에 용해된 용액상태로 이용된다. 이때 사용하는 용제는, (A)성분, (B)성분, 필요에 따라 (C)성분 및/또는 후술하는 기타 첨가제를 용해할 수 있으면 되며, 그 종류 및 구조 등은 특별히 한정되는 것은 아니다.The cured film formation composition of this invention is mainly used in the solution state melt | dissolved in the solvent. The solvent used at this time should just melt | dissolve (A) component, (B) component, (C) component and / or the other additive mentioned later as needed, and the kind, structure, etc. are not specifically limited.
용제의 구체예로는, 예를 들어, 메탄올, 에탄올, n-프로판올, 이소프로판올, n-부탄올, 이소부탄올, 2-메틸-1-부탄올, n-펜탄올, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 디에틸렌글리콜, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 프로필렌글리콜, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르, 프로필렌글리콜프로필에테르, 프로필렌글리콜프로필에테르아세테이트, 톨루엔, 자일렌, 메틸에틸케톤, 이소부틸메틸케톤, 시클로펜탄온, 시클로헥사논, 2-부탄온, 3-메틸-2-펜탄온, 2-펜탄온, 2-헵탄온, γ-부티로락톤, 2-하이드록시프로피온산에틸, 2-하이드록시-2-메틸프로피온산에틸, 에톡시아세트산에틸, 하이드록시아세트산에틸, 2-하이드록시-3-메틸부탄산메틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-에톡시프로피온산메틸, 3-에톡시프로피온산에틸, 피루브산메틸, 피루브산에틸, 아세트산에틸, 아세트산부틸, 유산에틸, 유산부틸, 시클로펜틸메틸에테르, N,N-디메틸포름아미드, N,N-디메틸아세트아미드, 및 N-메틸-2-피롤리돈 등을 들 수 있다.As a specific example of a solvent, For example, methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, 2-methyl-1- butanol, n-pentanol, ethylene glycol monomethyl ether, ethylene glycol mono Ethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene Glycol monoethyl ether, propylene glycol propyl ether, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone, isobutyl methyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2-pentane On, 2-pentanone, 2-heptanone, γ-butyrolactone, ethyl 2-hydroxypropionate, ethyl 2-hydroxy-2-methylpropionate, ethyl ethoxyacetate Ethyl hydroxy acetate, methyl 2-hydroxy-3-methylbutyrate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, methyl pyruvate, pyruvic acid Ethyl, ethyl acetate, butyl acetate, ethyl lactate, butyl lactate, cyclopentylmethyl ether, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone, and the like. .
본 발명의 경화막 형성 조성물을 이용하고, 수지필름 상에 경화막을 형성하여 배향재를 제조하는 경우는, 메탄올, 에탄올, n-프로판올, 이소프로판올, n-부탄올, 2-메틸-1-부탄올, 2-헵탄온, 이소부틸메틸케톤, 디에틸렌글리콜, 프로필렌글리콜, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노메틸에테르아세테이트 등이, 수지필름이 내성을 나타내는 용제라는 점으로부터 바람직하다.When using the cured film formation composition of this invention, a cured film is formed on a resin film and an orientation material is manufactured, methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-methyl-1- butanol, 2 -Heptanone, isobutyl methyl ketone, diethylene glycol, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, etc. are preferable at the point that a resin film is a solvent which shows tolerance.
이들 용제는, 1종 단독으로 또는 2종 이상의 조합으로 사용할 수 있다.These solvents can be used individually by 1 type or in combination of 2 or more types.
<기타 첨가제><Other additives>
나아가, 본 발명의 경화막 형성 조성물은, 본 발명의 효과를 손상시키지 않는 한, 필요에 따라, 증감제, 밀착향상제, 실란커플링제, 계면활성제, 레올로지조정제, 안료, 염료, 보존안정제, 소포제, 산화방지제 등을 함유할 수 있다.Furthermore, as long as the effect of this invention is not impaired, the cured film formation composition of this invention is a sensitizer, an adhesion promoter, a silane coupling agent, surfactant, a rheology regulator, a pigment, dye, a storage stabilizer, an antifoamer. And antioxidants.
<경화막 형성 조성물의 조제><Preparation of the cured film forming composition>
본 발명의 경화막 형성 조성물은, (A)성분의 수직배향성기와 C=C이중결합을 포함하는 중합성기를 갖는 폴리머, (B)성분의 중합개시제를 함유하고, 필요에 따라 (C)성분의 C=C이중결합을 포함하는 중합성기를 갖는 모노머 및 폴리머로 이루어지는 군으로부터 선택되는 적어도 1종, 그리고 추가로 본 발명의 효과를 손상시키지 않는 한 기타 첨가제를 함유할 수 있는 조성물이다. 그리고 통상은, 이들이 용제에 용해된 용액의 형태로서 이용된다.The cured film formation composition of this invention contains the polymer which has a vertical orientation group of (A) component, and a polymerizable group containing C = C double bond, and the polymerization initiator of (B) component, and if necessary, It is a composition which can contain at least 1 sort (s) chosen from the group which consists of a monomer and a polymer which have a polymerizable group containing C = C double bond, and the other additive, unless the effect of this invention is impaired. And usually, they are used as a form of the solution which melt | dissolved in the solvent.
본 발명의 경화막 형성 조성물의 바람직한 예는, 이하와 같다.The preferable example of the cured film formation composition of this invention is as follows.
[1]: (A)성분, (A)성분 100질량부에 기초하여, 0.1질량부~50질량부의 (B)성분을 함유하는 경화막 형성 조성물.[1]: Cured film formation composition containing 0.1 mass part-50 mass parts (B) component based on (A) component and 100 mass parts of (A) component.
[2]: (A)성분, (A)성분 100질량부에 기초하여, 0.1질량부~50질량부의 (B)성분, (A)성분 100질량부에 기초하여, 10질량부~1000질량부의 (C)성분, 그리고, 용제를 함유하는 경화막 형성 조성물.[2]: 10 parts by mass to 1000 parts by mass based on (B) component and 100 parts by mass of (A) component based on (A) component and 100 parts by mass of component (A) (C) component and the cured film formation composition containing a solvent.
본 발명의 경화막 형성 조성물을 용액으로서 이용하는 경우의 배합비율, 조제방법 등을 이하에 상술한다.The compounding ratio, preparation method, etc. at the time of using the cured film formation composition of this invention as a solution are explained in full detail below.
본 발명의 경화막 형성 조성물에 있어서의 고형분의 비율은, 각 성분이 균일하게 용제에 용해되어 있는 한, 특별히 한정되는 것은 아니나, 1질량%~60질량%이고, 바람직하게는 2질량%~50질량%이고, 보다 바람직하게는 2질량%~20질량%이다. 여기서, 고형분이란, 경화막 형성 조성물의 전체성분으로부터 용제를 제외한 것을 말한다.Although the ratio of solid content in the cured film formation composition of this invention is not specifically limited as long as each component is melt | dissolving uniformly in a solvent, It is 1 mass%-60 mass%, Preferably it is 2 mass%-50 It is mass%, More preferably, it is 2 mass%-20 mass%. Here, solid content means what remove | excluding the solvent from all the components of a cured film formation composition.
본 발명의 경화막 형성 조성물의 조제방법은, 특별히 한정되지 않는다. 조제법으로는, 예를 들어, 용제에 용해된 (A)성분의 용액에 (B)성분, 더 나아가 (C)성분 등을 소정의 비율로 혼합하고, 균일한 용액으로 하는 방법, 혹은, 이 조제법의 적당한 단계에 있어서, 필요에 따라 기타 첨가제를 추가로 첨가하여 혼합하는 방법을 들 수 있다.The preparation method of the cured film formation composition of this invention is not specifically limited. As a preparation method, for example, the method of mixing (B) component, Furthermore, (C) component etc. to the solution of (A) component melt | dissolved in a solvent in a predetermined ratio, and to make it a uniform solution, or this preparation method In the appropriate step of, there may be mentioned a method of further adding and mixing other additives as necessary.
또한, 조제된 경화막 형성 조성물의 용액은, 구멍직경이 0.2μm 정도인 필터 등을 이용하여 여과한 후, 사용하는 것이 바람직하다.Moreover, it is preferable to use the prepared solution of the cured film formation composition, after filtering using a filter etc. which are about 0.2 micrometer in pore diameter.
<경화막, 배향재 및 위상차재><Cured film, alignment material, and phase difference material>
본 발명의 경화막 형성 조성물의 용액을 기판(예를 들어, 실리콘/이산화실리콘피복기판, 실리콘나이트라이드기판, 금속, 예를 들어, 알루미늄, 몰리브덴, 크롬 등이 피복된 기판, 유리기판, 석영기판, ITO기판 등)이나 필름기판(예를 들어, 트리아세틸셀룰로오스(TAC)필름, 폴리카보네이트(PC)필름, 시클로올레핀폴리머(COP)필름, 시클로올레핀코폴리머(COC)필름, 폴리에틸렌테레프탈레이트(PET)필름, 아크릴필름, 폴리에틸렌필름 등의 수지필름) 등의 위에, 바코트, 회전도포, 흘림도포, 롤도포, 슬릿도포, 슬릿에 이은 회전도포, 잉크젯도포, 인쇄 등에 의해 도포하여 도막을 형성하고, 그 후, 핫플레이트 또는 오븐 등에서 가열건조함으로써, 경화막을 형성할 수 있다. 이 경화막은 그대로 배향재로서 적용할 수 있다.The solution of the cured film-forming composition of the present invention may be a substrate (for example, a silicon / silicon dioxide coated substrate, a silicon nitride substrate, a metal, for example, a substrate coated with aluminum, molybdenum, chromium, etc., a glass substrate, or a quartz substrate). , ITO substrate, etc.) or a film substrate (for example, triacetyl cellulose (TAC) film, polycarbonate (PC) film, cycloolefin polymer (COP) film, cycloolefin copolymer (COC) film, polyethylene terephthalate (PET)) A film, acrylic film, resin film such as polyethylene film), etc., by coating with a bar coat, rotary coating, shedding coating, roll coating, slit coating, slit followed by rotary coating, inkjet coating, printing, etc. Then, the cured film can be formed by heat-drying in a hotplate, oven, etc. This cured film can be applied as an orientation material as it is.
가열건조의 조건으로는, 경화막(배향재)의 성분이, 그 위에 도포되는 중합성 액정용액에 용출되지 않을 정도로, 가교제에 의한 가교반응이 진행되면 되고, 예를 들어, 온도 60℃~200℃, 시간 0.4분간~60분간의 범위 중에서 적당히 선택된 가열온도 및 가열시간이 채용된다. 가열온도 및 가열시간은, 바람직하게는 70℃~160℃, 0.5분간~10분간이다.As conditions for heat drying, the crosslinking reaction by a crosslinking agent should just advance so that the component of a cured film (orientation material) may not elute in the polymeric liquid crystal solution apply | coated on it, for example, temperature 60 degreeC-200 The heating temperature and heating time suitably selected from the range of 0, C and 0.4 minutes-60 minutes are employ | adopted. Heating temperature and heating time become like this. Preferably they are 70 degreeC-160 degreeC, and 0.5 minute-10 minutes.
본 발명의 경화성 조성물을 이용하여 형성되는 경화막(배향재)의 막두께는, 예를 들어, 0.05μm~5μm이고, 사용하는 기판의 단차나 광학적, 전기적 성질을 고려하여 적당히 선택할 수 있다.The film thickness of the cured film (alignment material) formed using the curable composition of this invention is 0.05 micrometer-5 micrometers, for example, and can select suitably in consideration of the level | step difference of the board | substrate to be used, and the optical and electrical property.
본 발명의 경화막 조성물로부터 형성된 배향재는 내용제성 및 내열성을 갖고 있으므로, 이 배향재 상에, 수직배향성을 갖는 중합성 액정용액 등의 위상차재료를 도포하고, 배향재 상에서 배향시킬 수 있다. 그리고, 배향상태가 된 위상차재료를 그대로 경화시킴으로써, 광학이방성을 갖는 층으로서 위상차재를 형성할 수 있다. 그리고, 배향재를 형성하는 기판이 필름인 경우에는, 위상차필름으로서 유용해진다.Since the orientation material formed from the cured film composition of this invention has solvent resistance and heat resistance, retardation materials, such as the polymeric liquid crystal solution which has a vertical orientation, can be apply | coated on this orientation material, and it can orientate on an orientation material. And the phase difference material can be formed as a layer which has optical anisotropy by hardening the phase difference material which became the orientation state as it is. And when the board | substrate which forms an orientation material is a film, it becomes useful as a retardation film.
또한, 상기와 같이 하여 형성된, 본 발명의 배향재를 갖는 2매의 기판을 이용하고, 스페이서를 개재하여 양 기판 상의 배향재가 서로 마주하도록 맞붙인 후, 이들 기판 사이에 액정을 주입하여, 액정이 배향된 액정표시소자로 할 수도 있다.In addition, by using two substrates having the alignment member of the present invention formed as described above, and pasting the alignment members on both substrates to face each other via a spacer, the liquid crystal is injected between these substrates to form a liquid crystal. It can also be set as an oriented liquid crystal display element.
이와 같이 본 발명의 경화막 형성 조성물은, 각종 위상차재(위상차필름)나 액정표시소자 등의 제조에 호적하게 이용할 수 있다.Thus, the cured film formation composition of this invention can be used suitably for manufacture of various retardation materials (retardation film), a liquid crystal display element, etc.
실시예Example
이하, 본 발명의 실시예를 들어, 본 발명을 구체적으로 설명하나, 본 발명은 이것들로 한정하여 해석되는 것은 아니다.Hereinafter, although an Example of this invention is given and this invention is demonstrated concretely, this invention is not limited to these and is interpreted.
[실시예에서 이용하는 약기호][Abbreviated sign used in the embodiment]
이하의 실시예에서 이용하는 약기호의 의미는, 다음과 같다.The meanings of the abbreviations used in the following examples are as follows.
<A성분의 원료><Raw material of component A>
LAA: 라우릴아크릴레이트LAA: Laurylacrylate
PAA: 팔미틸아크릴레이트PAA: Palmitylacrylate
HEMA: 2-하이드록시에틸메타크릴레이트HEMA: 2-hydroxyethyl methacrylate
GMA: 글리시딜메타크릴레이트GMA: glycidyl methacrylate
AOI: 쇼와덴코(주)제 카렌즈 AOIAoi: car lens AOI made by Showa Denko
AIBN: α,α’-아조비스이소부티로니트릴AIBN: α, α'-azobisisobutyronitrile
LA: 라우릴산LA: lauryl acid
M100: 3,4-에폭시시클로헥실메틸메타크릴레이트M100: 3,4-epoxycyclohexylmethyl methacrylate
5PCA: 4-(4-펜틸시클로헥실)안식향산5PCA: 4- (4-pentylcyclohexyl) benzoic acid
<B성분><Component B>
IRG: BASF사제 IRGACURE 907IRG: IRGACURE 907 made by BASF Corporation
OXE: BASF사제 IRGACURE OXE 02OXE: IRGACURE OXE 02 made by BASF Corporation
<C성분><C component>
DPHA: 다이셀올넥스(주)제 디펜타에리스리톨헥사아크릴레이트DPha: dipentaerythritol hexaacrylate made by Daicel Allnex Co., Ltd.
SMP: 쿄에이샤화학(주)제 UV경화형 아크릴폴리머 SMP-550ASMP: UV curing type acrylic polymer SMP-550A manufactured by Kyisha Chemical Co., Ltd.
<기타 ><Others>
MAA: 메타크릴산MAA: methacrylic acid
CYM303: 헥사메톡시메틸멜라민CYM303: Hexamethoxymethylmelamine
PTSA: p-톨루엔설폰산·일수화물PTSA: p-toluenesulfonic acid monohydrate
<용제><Solvent>
실시예 및 비교예의 각 경화막 형성 조성물은 용제를 함유하고, 그 용제로서, 프로필렌글리콜모노메틸에테르(PM), 아세트산부틸(BA), 아세트산에틸(EA)을 이용하였다.Each cured film formation composition of an Example and a comparative example contained a solvent, and propylene glycol monomethyl ether (PM), butyl acetate (BA), and ethyl acetate (EA) were used as the solvent.
<중합체의 분자량의 측정><Measurement of molecular weight of polymer>
중합예에 있어서의 아크릴 공중합체의 분자량은, (주)Shodex사제 상온 겔침투 크로마토그래피(GPC)장치(GPC-101), Shodex사제 컬럼(KD-803, KD-805)을 이용하고 이하와 같이 하여 측정하였다.The molecular weight of the acrylic copolymer in the polymerization example is as follows using the room temperature gel permeation chromatography (GPC) apparatus (GPC-101) by Shodex Corporation, and the column (KD-803, KD-805) by Shodex Corporation. It was measured by.
한편, 하기의 수평균분자량(이하, Mn이라 칭한다.) 및 중량평균분자량(이하, Mw라 칭한다.)은, 폴리스티렌 환산값으로 나타내었다.In addition, the following number average molecular weight (henceforth Mn) and a weight average molecular weight (henceforth Mw) were shown by polystyrene conversion value.
컬럼온도: 50℃Column temperature: 50 ℃
용리액: N,N-디메틸포름아미드(첨가제로서, 브롬화리튬일수화물(LiBr·H2O)가 30mmol/L, 인산·무수결정(o-인산)이 30mmol/L, 테트라하이드로푸란(THF)이 10mL/L)Eluent: N, N-dimethylformamide (as additive, lithium bromide monohydrate (LiBr.H 2 O) is 30 mmol / L, phosphoric acid anhydrous crystal (o-phosphate) is 30 mmol / L, tetrahydrofuran (THF) 10 mL / L)
유속: 1.0mL/분Flow rate: 1.0mL / min
검량선 작성용 표준샘플: 토소사제 TSK 표준 폴리에틸렌옥사이드(분자량 약 900,000, 150,000, 100,000, 30,000), 및, 폴리머래보라토리사제 폴리에틸렌글리콜(분자량 약 12,000, 4,000, 1,000).Standard sample for calibration curve preparation: TSK standard polyethylene oxide (molecular weight about 900,000, 150,000, 100,000, 30,000) by Tosoh Corporation, and polyethylene glycol (molecular weight about 12,000, 4,000, 1,000) by Polymer Laboratories.
<중합예 1><Polymerization Example 1>
LAA 3.0g, GMA 12.0g, 중합촉매로서 AIBN 0.3g을 PM 45.7g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴 공중합체용액을 얻었다. 얻어진 아크릴 공중합체용액을 헥산 500.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써 아크릴 공중합체(P1)를 얻었다. 얻어진 아크릴 공중합체의 Mn은 14,000, Mw는 38,000이었다.An acrylic copolymer solution was obtained by dissolving AIBN 0.3g in PM 45.7g as LAA 3.0g, GMA 12.0g, and a polymerization catalyst and reacting at 80 ° C for 20 hours. The obtained acrylic copolymer solution was slowly added dropwise to 500.0 g of hexane to precipitate a solid, and the acrylic copolymer (P1) was obtained by filtration and drying under reduced pressure. Mn of the obtained acrylic copolymer was 14,000 and Mw was 38,000.
<중합예 2><Polymerization Example 2>
PAA 3.0g, GMA 12.0g, 중합촉매로서 AIBN 0.3g을 PM 45.7g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴 공중합체용액을 얻었다. 얻어진 아크릴 공중합체용액을 헥산 500.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써 아크릴 공중합체(P2)를 얻었다. 얻어진 아크릴 공중합체의 Mn은 12,000, Mw는 30,000이었다.An acrylic copolymer solution was obtained by dissolving AIBN 0.3g in PM 45.7g as PAA 3.0g, GMA 12.0g, and a polymerization catalyst, and reacting at 80 degreeC for 20 hours. The obtained acrylic copolymer solution was slowly added dropwise to 500.0 g of hexane to precipitate a solid, and the acrylic copolymer (P2) was obtained by filtration and drying under reduced pressure. Mn of the obtained acrylic copolymer was 12,000 and Mw was 30,000.
<중합예 3><Polymerization Example 3>
LAA 3.0g, HEMA 12.0g, 중합촉매로서 AIBN 0.3g을 PM 45.7g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴 공중합체용액을 얻었다. 얻어진 아크릴 공중합체용액을 헥산 500.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써 아크릴 공중합체(P3)를 얻었다. 얻어진 아크릴 공중합체의 Mn은 8,600, Mw는 20,000이었다.An acrylic copolymer solution was obtained by dissolving 0.3 g of AIBN in 45.7 g of PM as LAA 3.0 g, HEMA 12.0 g, and a polymerization catalyst, and reacting at 80 ° C. for 20 hours. The obtained acrylic copolymer solution was slowly added dropwise to 500.0 g of hexane to precipitate a solid, and the acrylic copolymer (P3) was obtained by filtration and drying under reduced pressure. Mn of the obtained acrylic copolymer was 8,600 and Mw was 20,000.
<중합예 4><Polymerization Example 4>
LAA 1.5g, GMA 13.5g, 중합촉매로서 AIBN 0.3g을 PM 45.7g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴 공중합체용액을 얻었다. 얻어진 아크릴 공중합체용액을 헥산 500.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써 아크릴 공중합체(P4)를 얻었다. 얻어진 아크릴 공중합체의 Mn은 15,000, Mw는 32,000이었다.An acrylic copolymer solution was obtained by dissolving 0.3 g of AIBN in 45.7 g of PM as LAA 1.5 g, GMA 13.5 g, and a polymerization catalyst, and reacting at 80 ° C. for 20 hours. The obtained acrylic copolymer solution was gradually added dropwise to 500.0 g of hexane to precipitate a solid, and the acrylic copolymer (P4) was obtained by filtration and drying under reduced pressure. Mn of the obtained acrylic copolymer was 15,000 and Mw was 32,000.
<중합예 5><Polymerization Example 5>
LAA 4.5g, GMA 10.5g, 중합촉매로서 AIBN 0.3g을 PM 45.7g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴 공중합체용액을 얻었다. 얻어진 아크릴 공중합체용액을 헥산 500.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써 아크릴 공중합체(P5)를 얻었다. 얻어진 아크릴 공중합체의 Mn은 14,000, Mw는 31,000이었다.An acrylic copolymer solution was obtained by dissolving AIBN 0.3g in PM 45.7g as LAA 4.5g, GMA 10.5g, and a polymerization catalyst, and reacting at 80 ° C for 20 hours. The obtained acrylic copolymer solution was gradually added dropwise to 500.0 g of hexane to precipitate a solid, and the acrylic copolymer (P5) was obtained by filtration and drying under reduced pressure. Mn of the obtained acrylic copolymer was 14,000 and Mw was 31,000.
<중합예 6><Polymerization Example 6>
M100 10.0g, 중합촉매로서 AIBN 0.4g을 PM 46.4g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴 공중합체용액을 얻었다. 얻어진 아크릴 공중합체용액을 헥산 500.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써 아크릴 공중합체(P6)를 얻었다. 얻어진 아크릴 공중합체의 Mn은 18,000, Mw는 38,000이었다.An acrylic copolymer solution was obtained by dissolving 0.4 g of AIBN in 46.4 g of PM as 10.0 g of M100 and a polymerization catalyst and reacting at 80 ° C. for 20 hours. The obtained acrylic copolymer solution was gradually added dropwise to 500.0 g of hexane to precipitate a solid, and the acrylic copolymer (P6) was obtained by filtration and drying under reduced pressure. Mn of the obtained acrylic copolymer was 18,000 and Mw was 38,000.
<중합예 7><Polymerization Example 7>
MAA 13.8g, LAA 14.1g, HEMA 7.2g, 중합촉매로서 AIBN 0.68g을 PM 107.0g에 용해하고, 80℃에서 16시간 반응시킴으로써 아크릴 공중합체용액(고형분농도 25질량%)(P7)을 얻었다. 얻어진 아크릴 공중합체의 Mn은 13,300, Mw는 27,800이었다.The acrylic copolymer solution (solid content concentration of 25 mass%) (P7) was obtained by melt | dissolving AIBN0.68g in PM107.0g as MAA 13.8g, LAA 14.1g, HEMA 7.2g, and a polymerization catalyst, and making it react at 80 degreeC for 16 hours. Mn of the obtained acrylic copolymer was 13,300 and Mw was 27,800.
<합성예 1>Synthesis Example 1
중합예 1에서 얻은 아크릴 공중합체(P1) 7.5g, 아크릴산 4.5g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 30g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-1)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-1)가 아크로일기를 갖는 것을 확인하였다.7.5 g of acrylic copolymer (P1) obtained in Polymerization Example 1, 4.5 g of acrylic acid, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride were dissolved in 30 g of PM as a reaction catalyst and reacted at 110 ° C. for 20 hours. . This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-1) having an acroyl group. 1 H-NMR analysis was conducted to confirm that the acrylic copolymer (PA-1) had an acroyl group.
<합성예 2>Synthesis Example 2
중합예 2에서 얻은 아크릴 공중합체(P2) 7.5g, 아크릴산 4.5g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 30g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-2)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-2)가 아크로일기를 갖는 것을 확인하였다.7.5 g of acrylic copolymer (P2) obtained in Polymerization Example 2, 4.5 g of acrylic acid, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride were dissolved in 30 g of PM as a reaction catalyst and reacted at 110 ° C. for 20 hours. . This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-2) having an acroyl group. It was confirmed by 1 H-NMR analysis that the acrylic copolymer (PA-2) had an acroyl group.
<합성예 3>Synthesis Example 3
중합예 3에서 얻은 아크릴 공중합체(P3) 2.0g, 2-아크릴로일옥시에틸이소시아네이트 4.3g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 디부틸주석디라우레이트 10mg을 테트라하이드로푸란 60g에 용해시키고, 60℃에서 5시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-3)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-3)가 아크로일기를 갖는 것을 확인하였다.2.0 g of acrylic copolymer (P3) obtained in Polymerization Example 3, 4.3 g of 2-acryloyloxyethyl isocyanate, 0.4 g of dibutylhydroxytoluene, and 10 mg of dibutyltin dilaurate were dissolved in 60 g of tetrahydrofuran as a reaction catalyst. It was made to react at 60 degreeC for 5 hours. This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-3) having an acroyl group. It was confirmed by 1 H-NMR analysis that the acrylic copolymer (PA-3) had an acroyl group.
<합성예 4>Synthesis Example 4
중합예 4에서 얻은 아크릴 공중합체(P4) 6.8g, 아크릴산 4.5g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 30g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-4)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-4)가 아크로일기를 갖는 것을 확인하였다.6.8 g of acrylic copolymer (P4) obtained in Polymerization Example 4, 4.5 g of acrylic acid, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride were dissolved in 30 g of PM as a reaction catalyst and reacted at 110 ° C for 20 hours. . This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-4) having an acroyl group. 1 H-NMR analysis was conducted to confirm that the acrylic copolymer (PA-4) had an acroyl group.
<합성예 5>Synthesis Example 5
중합예 5에서 얻은 아크릴 공중합체(P5) 8.2g, 아크릴산 4.5g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 30g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-5)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-5)가 아크로일기를 갖는 것을 확인하였다.8.2 g of acrylic copolymer (P5) obtained in Polymerization Example 5, 4.5 g of acrylic acid, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride were dissolved in 30 g of PM as a reaction catalyst and reacted at 110 ° C for 20 hours. . This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-5) having an acroyl group. 1 H-NMR analysis was conducted to confirm that the acrylic copolymer (PA-5) had an acroyl group.
<합성예 6>Synthesis Example 6
중합예 6에서 얻은 아크릴 공중합체(P6) 8.0g, 아크릴산 2.4g, LA 1.6g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 50g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-6)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-6)가 아크로일기를 갖는 것을 확인하였다.8.0 g of acrylic copolymer (P6) obtained in Polymerization Example 6, 2.4 g of acrylic acid, 1.6 g of LA, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride as a reaction catalyst were dissolved in 50 g of PM, at 110 ° C. The reaction was carried out for 20 hours. This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-6) having an acroyl group. 1 H-NMR analysis was conducted to confirm that the acrylic copolymer (PA-6) had an acroyl group.
<합성예 7>Synthesis Example 7
중합예 6에서 얻은 아크릴 공중합체(P6) 8.0g, 아크릴산 1.8g, LA 1.7g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 50g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-7)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-7)가 아크로일기를 갖는 것을 확인하였다.8.0 g of acrylic copolymer (P6) obtained in Polymerization Example 6, 1.8 g of acrylic acid, 1.7 g of LA, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride as a reaction catalyst were dissolved in 50 g of PM, at 110 ° C. The reaction was carried out for 20 hours. This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-7) having an acroyl group. 1 H-NMR analysis was performed to confirm that the acrylic copolymer (PA-7) had an acroyl group.
<합성예 8>Synthesis Example 8
중합예 6에서 얻은 아크릴 공중합체(P6) 8.0g, 아크릴산 3.2g, 5PCA 2.2g, 디부틸하이드록시톨루엔 0.4g, 반응촉매로서 벤질트리에틸암모늄클로라이드 0.3g을 PM 60g에 용해시키고, 110℃에서 20시간 반응시켰다. 이 용액을 헥산 500g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 아크로일기를 갖는 아크릴 공중합체(PA-8)를 얻었다. 1H-NMR분석을 행하여, 아크릴 공중합체(PA-8)가 아크로일기를 갖는 것을 확인하였다.8.0 g of acrylic copolymer (P6) obtained in Polymerization Example 6, 3.2 g of acrylic acid, 2.2 g of 5PCA, 0.4 g of dibutylhydroxytoluene, and 0.3 g of benzyltriethylammonium chloride as a reaction catalyst were dissolved in 60 g of PM, at 110 ° C. The reaction was carried out for 20 hours. This solution was slowly added dropwise to 500 g of hexane to precipitate a solid, and filtered and dried under reduced pressure to obtain an acrylic copolymer (PA-8) having an acroyl group. 1 H-NMR analysis was performed to confirm that the acrylic copolymer (PA-8) had an acroyl group.
<실시예><Example>
표 1에 나타내는 조성으로 실시예의 각 경화막 형성 조성물을 조제하였다. 다음에, 각 경화막 형성 조성물을 이용하여 경화막을 형성하고, 얻어진 경화막 각각에 대하여, 수직배향성 및 밀착성의 평가를 행하였다.Each cured film formation composition of an Example was prepared with the composition shown in Table 1. Next, the cured film was formed using each cured film formation composition, and the vertical orientation and adhesiveness were evaluated about each obtained cured film.
[표 1]TABLE 1
<비교예>Comparative Example
WO2015/019962호에 기재된 방법을 참고로, 표 2에 나타내는 비교예의 각 경화막 형성 조성물을 조제하였다. 다음에, 각 경화막 형성 조성물을 이용하여 경화막을 형성하고, 얻어진 경화막 각각에 대하여, 수직배향성 및 밀착성의 평가를 행하였다.Each cured film formation composition of the comparative example shown in Table 2 was prepared with reference to the method of WO2015 / 019962. Next, the cured film was formed using each cured film formation composition, and the vertical orientation and adhesiveness were evaluated about each obtained cured film.
[수직배향성의 평가][Evaluation of Vertical Orientation]
실시예의 각 경화막 형성 조성물을, TAC필름 상에 바코터를 이용하여 Wet막두께 4μm로 도포하였다. 각각 온도 110℃에서 60초간, 열순환식 오븐 중에서 가열건조를 행하고, 그 후, 이 도막을 1000mJ/cm2로 노광하여, TAC필름 상에 각각 경화막을 형성하였다.Each cured film formation composition of an Example was apply | coated on the TAC film by 4 micrometers of Wet film thickness using the bar coater. Heat-drying was performed in a thermocyclic oven for 60 second at the temperature of 110 degreeC, respectively, Then, this coating film was exposed at 1000mJ / cm <2>, and the cured film was formed on TAC film, respectively.
이 경화막 상에, 메르크(주)제의 수직배향용 중합성 액정용액 RMS03-015를, 바코터를 이용하여 Wet막두께 6μm로 도포하였다. 이 도막을 500mJ/cm2로 노광하여, 위상차재를 제작하였다.On this cured film, the polymer liquid crystal solution RMS03-015 made by Merck Co., Ltd. was apply | coated to Wet film thickness of 6 micrometers using the bar coater. This coating film was exposed at 500mJ / cm <2> , and the phase difference material was produced.
제작한 이들 위상차재를, 오츠카전자(주)제 위상차측정장치 RETS100을 이용하여 면내위상차의 입사각도 의존성을 측정하였다. 입사각도 0도에서의 면내위상차값이 0, 입사각도 ±50도에서의 면내위상차가 38±5nm의 범위에 있는 것을 수직배향하고 있다고 판단하였다. 평가 결과는, 뒤에 표 3에 정리하여 나타낸다.Using these manufactured phase difference materials, the incidence angle dependence of the in-plane phase difference was measured using OTSKA Electronics Co., Ltd. phase difference measuring device RETS100. It was determined that the in-plane phase difference value at the incident angle of 0 degrees was 0 and the in-plane phase difference at the incident angle of ± 50 degrees was in the range of 38 ± 5 nm. The evaluation results are summarized in Table 3 later.
비교예의 각 경화막 형성 조성물을, TAC필름 상에 바코터를 이용하여 Wet막두께 4μm로 도포하였다. 각각 온도 110℃에서 60초간, 열순환식 오븐 중에서 가열건조를 행하여, TAC필름 상에 각각 경화막을 형성하였다.Each cured film formation composition of a comparative example was apply | coated on the TAC film by 4 micrometers of Wet film thickness using the bar coater. Heat-drying was performed in a thermocyclic oven for 60 second at the temperature of 110 degreeC, respectively, and the cured film was formed on TAC film, respectively.
이 경화막 상에, 메르크(주)제의 수직배향용 중합성 액정용액 RMS03-015를, 바코터를 이용하여 Wet막두께 6μm로 도포하였다. 이 도막을 500mJ/cm2로 노광하여, 위상차재를 제작하였다.On this cured film, the polymer liquid crystal solution RMS03-015 made by Merck Co., Ltd. was apply | coated to Wet film thickness of 6 micrometers using the bar coater. This coating film was exposed at 500mJ / cm <2> , and the phase difference material was produced.
제작한 이들 위상차재를, 오츠카전자(주)제 위상차측정장치 RETS100을 이용하여 면내위상차의 입사각도 의존성을 측정하였다. 입사각도 0도에서의 면내위상차값이 0, 입사각도 ±50도에서의 면내위상차가 38±5nm의 범위에 있는 것을 수직배향하고 있다고 판단하였다. 평가 결과는, 뒤에 표 3에 정리하여 나타낸다.Using these manufactured phase difference materials, the incidence angle dependence of the in-plane phase difference was measured using OTSKA Electronics Co., Ltd. phase difference measuring device RETS100. It was determined that the in-plane phase difference value at the incident angle of 0 degrees was 0 and the in-plane phase difference at the incident angle of ± 50 degrees was in the range of 38 ± 5 nm. The evaluation results are summarized in Table 3 later.
[밀착성의 평가][Evaluation of Adhesiveness]
실시예 및 비교예의 각 경화막 형성 조성물을, TAC필름 상에 바코터를 이용하여 Wet막두께 4μm로 도포하였다. 각각 온도 110℃에서 60초간, 열순환식 오븐 중에서 가열건조를 행하고, 그 후, 이 도막을 1000mJ/cm2로 노광하여, TAC필름 상에 각각 경화막을 형성하였다.Each cured film formation composition of an Example and a comparative example was apply | coated on the TAC film by 4 micrometers of Wet film thickness using the bar coater. Heat-drying was performed in a thermocyclic oven for 60 second at the temperature of 110 degreeC, respectively, Then, this coating film was exposed at 1000mJ / cm <2>, and the cured film was formed on TAC film, respectively.
이 경화막 상에, 메르크(주)제의 수직배향용 중합성 액정용액 RMS03-015를, 바코터를 이용하여 Wet막두께 6μm로 도포하였다. 이 기판 상의 도막을 500mJ/cm2로 노광하여, 위상차재를 제작하였다.On this cured film, the polymer liquid crystal solution RMS03-015 made by Merck Co., Ltd. was apply | coated to Wet film thickness of 6 micrometers using the bar coater. The coating film on this board | substrate was exposed at 500mJ / cm <2> , and the phase difference material was produced.
이 위상차재에 종횡 1mm 간격으로 5×5칸이 되도록 커터나이프로 칼집을 내었다. 이 칼집 위에 스카치테이프를 이용하여 셀로판테이프 박리시험을 행하였다. 평가는, 25칸 모두 벗겨지지 않고 남아 있는 것을 ○, 1칸이라도 벗겨져 있는 것을 ×로 하였다. 평가 결과는, 뒤에 표 3에 정리하여 나타낸다.The retarder was cut with a cutter knife so as to be 5 x 5 spaces at 1 mm intervals. On this sheath, the cellophane tape peeling test was done using Scotch tape. Evaluation was made into what the thing which peeled off even if one of the space | columns which remain | survived without peeling all 25 space | columns. The evaluation results are summarized in Table 3 later.
표 3에 나타내는 바와 같이, 실시예의 경화막 형성 조성물을 이용하여 얻어진 배향재는, 비교예의 경화막 형성 조성물을 이용하여 얻어진 배향재와 마찬가지로, 양호한 수직배향성을 나타내었다.As shown in Table 3, the orientation material obtained using the cured film formation composition of an Example showed the favorable vertical orientation similarly to the orientation material obtained using the cured film formation composition of a comparative example.
실시예의 경화막 형성 조성물을 이용하여 얻어진 경화막은, 우수한 밀착성을 나타내었다. 이에 반해, 비교예의 경화막 형성 조성물을 이용하여 얻어진 경화막은, 밀착성을 얻는 것이 곤란하였다.The cured film obtained using the cured film formation composition of an Example showed the outstanding adhesiveness. On the other hand, the cured film obtained using the cured film formation composition of a comparative example was difficult to acquire adhesiveness.
산업상 이용가능성Industrial availability
본 발명에 따른 경화막 형성 조성물은, 액정표시소자의 액정배향막이나, 액정표시소자의 내부나 외부에 마련되는 광학이방성필름을 형성하기 위한 배향재를 형성하는 재료로서 매우 유용하며, 특히, IPS-LCD나, 유기 EL디스플레이의 반사방지막으로서 사용되는 원편광판의 광학보상필름용 재료로서 호적하다.The cured film formation composition which concerns on this invention is very useful as a material which forms the orientation material for forming the liquid crystal aligning film of a liquid crystal display element, or the optically anisotropic film provided in the inside or the exterior of a liquid crystal display element, Especially, IPS- It is suitable as an optical compensation film material of a circular polarizing plate used as an antireflection film of LCD and an organic EL display.
Claims (7)
(B)라디칼중합개시제
를 함유하는 경화막 형성 조성물로서,
상기 수직배향성기는 하기 식(1)로 표시되는 기인 것을 특징으로 하는, 경화막 형성 조성물.
[화학식 1]
(식 [1] 중,
Y1은 단결합 또는 결합기를 나타내고,
Y2는 단결합, 탄소원자수 1~15의 알킬렌기 혹은 -CH2-CH(OH)-CH2-를 나타내거나, 또는 벤젠환, 시클로헥산환 혹은 복소환으로부터 선택되는 2가의 환상기를 나타내고, 상기 환상기 상의 임의의 수소원자가, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있고,
Y3은 단결합 또는 탄소원자수 1~15의 알킬렌기를 나타내고,
Y4는 단결합을 나타내거나, 또는 벤젠환, 시클로헥산환 혹은 복소환으로부터 선택되는 2가의 환상기, 또는 탄소원자수 17~30으로서 스테로이드골격을 갖는 2가의 유기기를 나타내고, 상기 환상기 상의 임의의 수소원자가, 하이드록시기, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있고,
Y5는 벤젠환, 시클로헥산환 또는 복소환으로부터 선택되는 2가의 환상기를 나타내고, 이들 환상기 상의 임의의 수소원자가, 하이드록시기, 탄소원자수 1~3의 알킬기, 탄소원자수 1~3의 알콕실기, 탄소원자수 1~3의 불소함유 알킬기, 탄소원자수 1~3의 불소함유 알콕실기 또는 불소원자로 치환되어 있을 수도 있고,
n은 0~4의 정수를 나타내고, n이 2 이상인 경우, Y5끼리는 동일할 수도 상이할 수도 있고,
Y6은 수소원자, 탄소원자수 1~18의 알킬기, 탄소원자수 1~18의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 또는 탄소원자수 1~18의 불소함유 알콕실기를 나타내고,
Y2 및 Y3에 있어서의 알킬렌기, 그리고, 상기 환상기 상의 치환기 및 Y6에 있어서의 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 직쇄상, 분지상, 혹은 환상 중 어느 하나 또는 이들의 조합일 수도 있고,
또한 Y2 및 Y3에 있어서의 알킬렌기, 그리고, Y6에 있어서의 알킬기, 불소함유 알킬기, 알콕실기 및 불소함유 알콕실기는, 결합기끼리가 서로 이웃하지 않는 한 1 내지 3의 결합기로 중단되어 있을 수도 있고,
나아가 Y2, Y4 혹은 Y5가 2가의 환상기를 나타내거나, 또는 Y4가 스테로이드골격을 갖는 2가의 유기기를 나타내거나, 또는 Y2가 -CH2-CH(OH)-CH2-를 나타내거나, 또는 Y2 혹은 Y3이 알킬렌기를 나타내거나, 또는 Y6이 알킬기 혹은 불소함유 알킬기를 나타낼 때, 이 2가의 환상기, 이 스테로이드골격을 갖는 2가의 유기기, 이 -CH2-CH(OH)-CH2-, 이 알킬렌기, 이 알킬기 및 이 불소함유 알킬기는, 이것들에 인접하는 기와 결합기를 개재하여 결합하고 있을 수도 있고,
그리고 상기 결합기는, -O-, -CH2O-, -COO-, -OCO-, -NHCO-, -NH-CO-O- 및 -NH-CO-NH-로 이루어지는 군으로부터 선택되는 기를 나타내고,
단, Y2 내지 Y6이 각각 나타내는 바의 단결합, 탄소원자수 1~15의 알킬렌기, 벤젠환, 시클로헥산환, 복소환, 스테로이드골격을 갖는 2가의 유기기, -CH2-CH(OH)-CH2-, 탄소원자수 1~18의 알킬기, 탄소원자수 1~18의 불소함유 알킬기, 탄소원자수 1~18의 알콕실기 및 탄소원자수 1~18의 불소함유 알콕실기의 탄소원자수의 합계는 6~30이다).(A) a polymer having a vertically oriented group and a polymerizable group containing a C = C double bond, and
(B) radical polymerization initiator
As a cured film formation composition containing
Said vertical orientation group is group represented by following formula (1), The cured film formation composition characterized by the above-mentioned.
[Formula 1]
(In formula [1],
Y 1 represents a single bond or a bonding group,
Y 2 represents a single bond, an alkylene group having 1 to 15 carbon atoms, or —CH 2 —CH (OH) —CH 2 —, or a divalent cyclic group selected from a benzene ring, a cyclohexane ring, or a hetero ring, Any hydrogen atom on the cyclic group is substituted with an alkyl group having 1 to 3 carbon atoms, an alkoxyl group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom May be,
Y 3 represents a single bond or an alkylene group having 1 to 15 carbon atoms,
Y 4 represents a single bond or a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, or a divalent organic group having a steroid skeleton as 17 to 30 carbon atoms, and optionally Hydrogen atom may be substituted with a hydroxy group, an alkyl group having 1 to 3 carbon atoms, an alkoxyl group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom Maybe,
Y 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on these cyclic groups is a hydroxy group, an alkyl group having 1 to 3 carbon atoms, or an alkoxyl group having 1 to 3 carbon atoms May be substituted with a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxyl group having 1 to 3 carbon atoms, or a fluorine atom,
n represents the integer of 0-4, and when n is 2 or more, Y <5> may be same or different,
Y 6 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxyl group having 1 to 18 carbon atoms or a fluorine-containing alkoxyl group having 1 to 18 carbon atoms,
The alkylene group in Y 2 and Y 3 , and the substituent on the cyclic group and the alkyl group, fluorine-containing alkyl group, alkoxyl group and fluorine-containing alkoxyl group in Y 6 are either linear, branched or cyclic. Or a combination thereof,
In addition, the alkylene group for Y 2 and Y 3 , and the alkyl group, fluorine-containing alkyl group, alkoxyl group and fluorine-containing alkoxyl group for Y 6 are interrupted by a bond of 1 to 3 unless the bonding groups are adjacent to each other. Maybe
Furthermore, Y 2 , Y 4 or Y 5 represents a divalent cyclic group, Y 4 represents a divalent organic group having a steroid skeleton, or Y 2 represents -CH 2 -CH (OH) -CH 2-. Or when Y 2 or Y 3 represents an alkylene group, or Y 6 represents an alkyl group or a fluorine-containing alkyl group, the divalent cyclic group, the divalent organic group having the steroid skeleton, the -CH 2 -CH (OH) —CH 2 —, this alkylene group, this alkyl group and this fluorine-containing alkyl group may be bonded via a group and a bonding group adjacent to these,
And the linking group represents a group selected from the group consisting of -O-, -CH 2 O-, -COO-, -OCO-, -NHCO-, -NH-CO-O-, and -NH-CO-NH-. ,
Provided that each of Y 2 to Y 6 represents a single bond, an alkylene group having 1 to 15 carbon atoms, a benzene ring, a cyclohexane ring, a heterocycle, a divalent organic group having a steroid skeleton, -CH 2 -CH (OH ) -CH 2 -, the sum of carbon atoms of 1 to 18 alkyl group, a carbon atom number of 1 to 18 fluorinated alkyl group, a carbon atom number of 1 to 18 carbon atoms and an alkoxyl group of 1 to 18 carbon atoms, a fluorine-containing alkoxyl group of the 6 ~ 30).
(A)성분의 폴리머에 있어서, C=C이중결합을 포함하는 중합성기가, 아크릴기, 메타크릴기, 비닐기, 알릴기 및 말레이미드기로 이루어지는 군으로부터 선택되는 적어도 1종인, 경화막 형성 조성물.The method of claim 1,
In the polymer of (A) component, the cured film formation composition whose polymerizable group containing C = C double bond is at least 1 sort (s) chosen from the group which consists of an acryl group, a methacryl group, a vinyl group, an allyl group, and a maleimide group. .
(C)C=C이중결합을 포함하는 중합성기를 갖는 모노머 및 폴리머로 이루어지는 군으로부터 선택되는 적어도 1종을 추가로 함유하는, 경화막 형성 조성물.The method according to claim 1 or 2,
(C) Cured film formation composition which further contains at least 1 sort (s) chosen from the group which consists of a monomer and polymer which have a polymeric group containing C = C double bond.
(A)성분 100질량부에 기초하여, 0.1질량부~50질량부의 (B)성분을 함유하는, 경화막 형성 조성물.The method according to any one of claims 1 to 3,
Cured film formation composition containing 0.1 mass part-50 mass parts (B) component based on 100 mass parts of (A) component.
(A)성분의 100질량부에 기초하여, 10질량부 내지 1000질량부의 (C)성분을 함유하는, 경화막 형성 조성물.The method according to claim 3 or 4,
Cured film formation composition containing 10 mass parts-1000 mass parts (C) component based on 100 mass parts of (A) component.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017004141 | 2017-01-13 | ||
JPJP-P-2017-004141 | 2017-01-13 | ||
PCT/JP2018/000657 WO2018131682A1 (en) | 2017-01-13 | 2018-01-12 | Cured film forming composition, alignment material and retardation material |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190103295A true KR20190103295A (en) | 2019-09-04 |
KR102662074B1 KR102662074B1 (en) | 2024-05-02 |
Family
ID=62840344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020197022789A KR102662074B1 (en) | 2017-01-13 | 2018-01-12 | Cured film forming composition, orientation material and phase difference material |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP7070839B2 (en) |
KR (1) | KR102662074B1 (en) |
CN (1) | CN110167980B (en) |
TW (1) | TWI761424B (en) |
WO (1) | WO2018131682A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020181148A (en) * | 2019-04-26 | 2020-11-05 | 日産化学株式会社 | Retardation material |
TW202202878A (en) * | 2020-03-09 | 2022-01-16 | 日商大日本印刷股份有限公司 | Stacked body for flexible display, stacked body for display and flexible display |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02256023A (en) | 1988-11-04 | 1990-10-16 | Fuji Photo Film Co Ltd | Liquid crystal display device |
JPH11133408A (en) | 1997-10-24 | 1999-05-21 | Nec Corp | Horizontal electric field type liquid crystal display device |
JP2001281669A (en) | 2000-03-30 | 2001-10-10 | Matsushita Electric Ind Co Ltd | Liquid crystal alignment layer, its manufacturing method and liquid crystal display device and its manufacturing method |
JP2008116809A (en) * | 2006-11-07 | 2008-05-22 | Nissan Chem Ind Ltd | Resin composition for forming liquid crystal orientation layer |
JP2009122715A (en) | 2003-10-22 | 2009-06-04 | Lg Chem Ltd | Ips liquid crystal display comprising compensation film for angular field of view using positive a-plate and positve c-plate |
JP2015079256A (en) | 2014-11-11 | 2015-04-23 | 大日本印刷株式会社 | Optical film, transfer body for optical film, and image display device |
KR20160120485A (en) * | 2015-04-08 | 2016-10-18 | 주식회사 엘지화학 | Vertical alignment layer and liquid crystal device comprising the same |
KR20160127725A (en) * | 2014-02-28 | 2016-11-04 | 닛산 가가쿠 고교 가부시키 가이샤 | Cured-film-forming composition, alignment material, and phase difference material |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240615A (en) * | 2000-02-29 | 2001-09-04 | Nippon Shokubai Co Ltd | Reactive liquid polymer and method for producing the same |
JP2008292677A (en) | 2007-05-23 | 2008-12-04 | Mitsubishi Chemicals Corp | Reactive resin composition, color filter, and image display device |
JP2009236942A (en) * | 2008-03-25 | 2009-10-15 | Fujifilm Corp | Planographic printing plate precursor and plate making method of the same |
JP5552266B2 (en) * | 2009-06-24 | 2014-07-16 | 昭和電工株式会社 | Method for producing photocurable resin composition dispersed in aqueous medium |
JP2011032365A (en) * | 2009-07-31 | 2011-02-17 | Natoko Kk | Active energy ray-curable composition |
JP2011221463A (en) * | 2010-04-14 | 2011-11-04 | Samsung Electronics Co Ltd | Photosensitive resin composition |
JP5603177B2 (en) * | 2010-09-07 | 2014-10-08 | 関西ペイント株式会社 | Copolymer, aqueous coating composition containing the copolymer, and method for forming a multilayer coating film |
CN105452404B (en) * | 2013-08-09 | 2021-07-13 | 日产化学工业株式会社 | Composition for forming cured film, alignment material, and phase difference material |
CN111240102B (en) | 2014-08-28 | 2022-11-15 | 日产化学工业株式会社 | Composition for forming cured film, alignment material, and phase difference material |
CN106796373B (en) * | 2014-09-08 | 2021-02-19 | 日产化学工业株式会社 | Composition for forming cured film, alignment material, and phase difference material |
WO2016167231A1 (en) * | 2015-04-17 | 2016-10-20 | 日産化学工業株式会社 | Thermosetting resin composition and homeotropic alignment phase difference film |
CN105936830A (en) * | 2016-04-22 | 2016-09-14 | 深圳市华星光电技术有限公司 | Liquid crystal material, liquid crystal display panel manufacturing method and liquid crystal display panel |
-
2018
- 2018-01-12 CN CN201880006538.XA patent/CN110167980B/en active Active
- 2018-01-12 JP JP2018561429A patent/JP7070839B2/en active Active
- 2018-01-12 TW TW107101202A patent/TWI761424B/en active
- 2018-01-12 KR KR1020197022789A patent/KR102662074B1/en active IP Right Grant
- 2018-01-12 WO PCT/JP2018/000657 patent/WO2018131682A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02256023A (en) | 1988-11-04 | 1990-10-16 | Fuji Photo Film Co Ltd | Liquid crystal display device |
JPH11133408A (en) | 1997-10-24 | 1999-05-21 | Nec Corp | Horizontal electric field type liquid crystal display device |
JP2001281669A (en) | 2000-03-30 | 2001-10-10 | Matsushita Electric Ind Co Ltd | Liquid crystal alignment layer, its manufacturing method and liquid crystal display device and its manufacturing method |
JP2009122715A (en) | 2003-10-22 | 2009-06-04 | Lg Chem Ltd | Ips liquid crystal display comprising compensation film for angular field of view using positive a-plate and positve c-plate |
JP2008116809A (en) * | 2006-11-07 | 2008-05-22 | Nissan Chem Ind Ltd | Resin composition for forming liquid crystal orientation layer |
KR20160127725A (en) * | 2014-02-28 | 2016-11-04 | 닛산 가가쿠 고교 가부시키 가이샤 | Cured-film-forming composition, alignment material, and phase difference material |
JP2015079256A (en) | 2014-11-11 | 2015-04-23 | 大日本印刷株式会社 | Optical film, transfer body for optical film, and image display device |
KR20160120485A (en) * | 2015-04-08 | 2016-10-18 | 주식회사 엘지화학 | Vertical alignment layer and liquid crystal device comprising the same |
Also Published As
Publication number | Publication date |
---|---|
TW201831538A (en) | 2018-09-01 |
KR102662074B1 (en) | 2024-05-02 |
JP7070839B2 (en) | 2022-05-18 |
CN110167980B (en) | 2022-09-20 |
JPWO2018131682A1 (en) | 2019-11-07 |
TWI761424B (en) | 2022-04-21 |
CN110167980A (en) | 2019-08-23 |
WO2018131682A1 (en) | 2018-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9416317B2 (en) | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and optical anisotropic body | |
KR102339084B1 (en) | Cured-film-forming composition, alignment material, and phase difference material | |
KR102333902B1 (en) | Composition for forming cured film, alignment material, and retardation material | |
JP6604483B2 (en) | Cured film forming composition, alignment material and retardation material | |
KR102406797B1 (en) | Cured-film-forming composition, alignment material, and phase difference material | |
KR102662074B1 (en) | Cured film forming composition, orientation material and phase difference material | |
CN107532006B (en) | Thermosetting resin composition and vertically aligned retardation film | |
KR102481772B1 (en) | Composition for forming cured film, alignment material, and retardation material | |
KR20190116319A (en) | Cured film formation composition, orientation material, and phase difference material | |
KR20200093068A (en) | Cured film forming composition, alignment material and retardation material | |
TWI822746B (en) | Cured film forming composition, alignment material and retardation material | |
JP2020181148A (en) | Retardation material | |
CN111164120A (en) | Composition for forming cured film, alignment material, and phase difference material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E90F | Notification of reason for final refusal | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) |